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SUMMARY 
This thesis explores the connected areas of compulsive buying and compulsive 
hoarding. The study is divided into two main sections. The first section is a 
critical review of the empirical evidence of treatments for compulsive buying 
undertaken through a detailed search and examination of published literature. 
The second section presents a research report of a single case experimental 
evaluation of cognitive-behavioural treatment of compulsive hoarding.  
 
Section 1 – Literature Review Abstract:  
The current paper describes and critically reviews pharmacological and 
psychotherapeutic treatment studies of compulsive buying (CB). Current 
conceptual and theoretical issues surrounding the classification and 
conceptualisation of CB are discussed. The prevalence, epidemiology and co-
morbidity of CB with other psychiatric disorders (particularly compulsive 
hoarding) are described. Each published treatment study of compulsive buying 
is critically reviewed in terms of its methodological design and findings. The 
limitations of the current evidence base for the treatment of compulsive buying 
are drawn in terms of conceptualisation/classification, measurement, and 
sampling methods. Recommendations for future CB outcome research are 
provided.    
 
Section 2 – Research Report Abstract: 
The current study describes an Object-Affect Fusion (OAF) informed Cognitive-
Behavioural Therapy (CBT) intervention with a 63-year old woman with 
compulsive hoarding. A single-case experimental design time-series analysis 
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was employed on 2-years of patient daily diary data relating to cognitive, 
behavioural and emotional factors in the lived experience of a compulsive 
hoarder.  The patient showed statistically significant increases in incidence, 
frequency and volume of discard as a result of the intervention. Clinically 
reliable changes on a range of clinical outcome measures, including depression, 
general mental health, and compulsive acquisition and saving were noted. 
Visual clutter ratings showed reliable change in the upstairs area of the home 
only. Additional domiciliary visits as part of treatment protocol did not lead to 
increases in discard. Patient self-reported hoarding related cognitions, 
behaviour and affect showed statistically reliable reductions with exception of 
depression and shame. Results of the study provide preliminary evidence that 
OAF informed CBT interventions have clinical utility in the treatment of 
compulsive hoarding. Methodological limitations of the study, suggestions for 
future research and implications for clinical practice are discussed.     
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Compulsive buying: a critical review of the theoretical and empirical 
evidence regarding treatment effectiveness 
 
1. Aim 
To many, shopping is seen as a pleasurable leisure activity and part of 
everyday life (Lunt & Livingstone, 1992). In compulsive buying (CB), the urge to 
buy (regardless of personal need or cost) is so powerful, that it becomes 
uncontrollable, intrusive and senseless (e.g. McElroy, Keck, Pope, Smith & 
Strakowski, 1994).  Compulsive buyers can be secretive and deeply ashamed 
of their problem and few seek help for fear of negative evaluation or 
stigmatisation (Benson, 2000). Compulsive buying has long been trivialised as 
the “smiled upon addiction” (Catalano & Soneberg, 1993).  It is only in recent 
years that CB has begun to receive serious interest from researchers and 
clinicians alike. The conceptual and theoretical understanding of CB is still in its 
empirical infancy and is matched by the limited CB outcome evidence base.  
 
The aim of this literature review is to firstly summarise current understanding of 
CB. Specific factors thought to be important in the development of CB, as well 
as its epidemiology, prevalence and co-morbidity with other disorders is 
presented. Current challenges surrounding the conceptual and definitional 
aspects of CB will be considered. The literature review will then describe and 
evaluate the current evidence base relating to the treatment of CB, and critique 
available research findings in terms of methodological rigour. The review will 
conclude by providing direction for future research.   
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2. Search strategy and inclusion/exclusion criteria 
Two major electronic databases – PsycINFO via OVIDSP 1806- present) and 
Web of Science (via Web of Knowledge 1900-present) were searched in 
January 2010. Searches were limited to literature in English. Search terms 
inputted into the database included „compulsive AND buying‟ OR „compulsive 
AND shopping‟, OR „compulsive AND spending‟ which were first searched 
separately in abstract, keyword or title. Further search terms inputted included 
„treatments‟ (exploded) OR „interventions‟ (exploded) OR „outcome‟ (exploded) 
in abstract, keyword or title. The results of the two separate searches were then 
combined using the Boolean operator AND in the search fields. Combined 
results of PsycINFO and Web of Science retrieved a total of 222 papers 
referred to either compulsive buying, compulsive shopping or compulsive 
spending. Both search engines retrieved a combined total of over 500,000 
papers related to interventions, treatments or outcome.  A total of 67 papers 
were retrieved as a result of combining studies referring to compulsive buying, 
shopping or spending with studies referring to treatment, intervention or 
outcome. The abstracts of these papers were then hand searched.  Papers 
which did not describe specific treatments or interventions for compulsive 
buying were excluded (n=50). A total of 17 papers were selected for final 
inclusion in the review.  
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3. Introduction to compulsive buying 
The phenomenon of CB has been recognised since the early 1900‟s, via 
qualitative case reports (e.g. Bleuler, 1923; Kraeplin, 1909) and more recently 
within psychodynamic case literature (e.g. Krueger, 1988; Laurence, 1990; 
Winestine, 1985). Compulsive buying (CB) disorder is a chronic and disabling 
condition (Kyrios, Frost & Skeketee, 2004), characterised by a maladaptive 
preoccupation with buying or shopping. The urge to shop is typically 
experienced as intrusive and irresistible, creating intolerable affect which tends 
to be relieved when a purchase is made (Black, 2007).  Individuals with CB 
show a preoccupation with shopping, spending and keeping up with latest 
fashion trends and can spend hours per week engaging in shopping behaviour 
(Black, 2007). CB significantly interferes with social and/or occupational 
functioning (Black, 2007), causes significant financial problems (with cases of 
individuals with debts over $30,000 on credit cards – see Black, Gabel, Hansen 
& Schlosser, 2000 for example). 
 
4. Classification of compulsive buying 
The definitive classification of compulsive buying is contentious (Black, 2007 
p.14). Compulsive buying is not recognised as a disorder in its own right within 
the DSM-IV-TR (APA, 2000), and falls within a broader category of „impulse 
control disorder - not otherwise specified‟ (APA, 2000).  
 
An ongoing theoretical issue is whether CB is best represented under the 
„impulse control disorders‟ umbrella, or whether it is more representative of 
obsessive-compulsive processes (Kellett, 2009 p. 86).  Impulse control 
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disorders (ICD‟s) (currently including intermittent explosive disorder, 
kleptomania, compulsive gambling, pyromania and trichotillomania) describe 
irresistible, impulsive and uncontrollable urges, characterised by increasing 
feelings of anxiety and tension, which are relieved through action, providing a 
sense of pleasure or gratification (APA, 2000). Compulsive disorders (e.g. 
obsessive compulsive disorder, OCD), refer to the performance of repetitive 
behaviours with the aim of reducing anxiety or distress, but which are not for the 
primary purpose of pleasure or gratification (APA, 2000). The exact nature of 
the relationship between ICD‟s and OCD is currently unknown; it being likely 
that there is a complex interplay between the two (Grant & Potenza, 2006). 
Current diagnostic criteria for CB (e.g. McElroy, Keck, Pope, Smith & 
Strakowski, 1994) suggest that CB may contain both impulsive and compulsive 
qualities.  
 
5. Antecedents of compulsive buying  
Current research relating to potential antecedents of CB falls into three main 
areas, namely; familial, psychological and social. Evidence from family studies 
suggests persons with CB are more likely to have received parental care and 
attention via material gifts such as money or „treats‟ (Scherhorn, 1990) and 
have childhood environments lacking in emotional warmth and nurturance 
(Krueger, 1988), and are more likely to report low self esteem during childhood 
(Faber, 1992). Compared to matched controls, individuals with CB have first-
degree relatives with higher incidences of psychiatric morbidity and dysfunction 
including depression, substance misuse and alcoholism (Black, Repertinger, 
Gaffney & Gabel, 1998). Whilst CB effectively temporarily relieves negative 
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emotional and psychological states, any associated benefit is subsequently 
overshadowed by feelings of guilt and depression when the reality of shopping 
binges is realised (Christenson, Faber, de Zwann, Raymond, Specker, Eckern, 
Mackenzie, Crosby, Crow, Eckert, Mussell & Mitchell, 1994). CB then becomes 
a cyclical process, to both bolster self esteem and relieve the guilt and low 
mood, resulting from shopping episodes (Kellett, 2009). Other researchers 
define CB as a socially created problem (e.g. Lee & Mysyk, 2004), arising from 
a culture of easily accessible consumer credit (Dittmar & Drury, 2000). Black, 
(2007) argues such socially determined approaches undermine the 
psychological and emotional distress experienced by individuals with CB and 
attempts to treat this disorder. 
 
6. Prevalence of compulsive buying 
There is a limited amount of research attesting to the prevalence rates of CB.  
Early studies conducted in the USA, estimated prevalence between 1.8% 
(Faber & O‟Guinn, 1992) and 16% (Magee, 1994). A more recent study of a 
large general population sample (n= 2,513) later placed this estimate at around 
5.8% (Koran, Faber, Aboujaoude, Large & Serpe, 2006). A German based 
survey of CB conducted in the early 1990‟s, estimated prevalence of CB in 
West Germany to be 5.1%, whilst only 1% in East Germany (Scherhorn, Reisch 
& Raab, 1990). In the following 10 years, as modernisation, consumer culture 
and social participation increased, particularly within old East Germany, so did 
the prevalence of CB; up to 8% for West Germans and 6.5% for East Germans 
(Neuner, Raab & Reisch, 2005). This suggests economic prosperity and 
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resultant cultural changes appear to impact upon increased rates of compulsive 
buying, highlighting the need for a biopsychosocial perspective. 
 
7. Epidemiology of compulsive buying  
The typical age of onset of CB is estimated to be between 18 to 30 years 
(Black, 1996). Early estimates suggested approximately 80-95% of individuals 
with CB were women (Black, 1996). Some argue gender differences in CB may 
not necessarily reflect a greater frequency of CB amongst women, but rather 
the different conceptualisations of „buying‟ behaviour between men and women. 
Women more likely to state that they enjoy „shopping‟ whereas men are more 
likely to use the term „collecting‟ to describe their patterns of consumption 
(Black, 2007 p.14). A more recent large sample CB study suggested that rates 
of CB are in fact comparable between both men (1.3%) and women (1.5%) 
respectively (Koran, Faber, Aboujaoude, Large & Serpe, 2006).  
 
8. Psychiatric co-morbidity in compulsive buying  
Table 1 summarises treatment and non-treatment studies with reported levels of 
psychiatric co-morbidity in CB samples. As the data illustrate, CB tends to have 
a high rate of co-morbidity with other psychiatric problems, frequently including 
anxiety and depression (e.g. Black, 1998; Black, Monahan & Gabel,1997; 
Black, Gabel, Hansen & Schlosser, 2000; Christenson, Faber, de Zwann, & 
Raymond, 1994; McElroy, Satlin, Pope, Keck & Hudson, 1991; McElroy et 
al.,1994; Mertens, Silberman, Mitchell & de Zwann, 2007; Mueller, Mueller, 
Albert, Mueller, Mueller, Silberman, Reinecker, Bleich, Mitchell and de Zwann, 
2008; Ninan, McElroy, Kane, Knight, Bettina, Casuto, Rose, Marsteller & 
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Nemeroff, 2000), obsessive compulsive disorder (e.g. Christenson, Faber, de 
Zwann, & Raymond, 1994), and pathological gambling (e.g. Black, Gabel, 
Hansen & Schlosser, 2000; Schlosser, Black, Repertinger & Freet, 1994). 
Table 1. Rates of CB co-morbidity across treatment and non-treatment studies 
Treatment studies 
Diagnosis McElroy et 
al., (1991) 
 
N=3 
Outpatient 
sample 
 
 
 
% 
McElroy et 
al., (1994) 
 
N=20 
Outpatient 
sample 
 
 
 
% 
Black et al., 
(1997) 
 
N= 10 
Community 
sample 
 
 
 
% 
Black et al., 
(1998) 
 
N=33 
Community 
sample 
 
 
 
% 
Ninan et al., 
(2000) 
 
N=42 
Outpatient 
and 
community 
sample 
 
% 
Koran et al., 
(2002) 
 
N=24 
Community 
sample 
 
 
 
% 
Koran et al., 
(2003) 
 
N=24 
Community 
sample 
 
 
 
% 
Mitchell et al., 
(2006) 
 
N= 39 
Community 
sample 
 
 
 
% 
Koran et al., 
(2007) 
 
N=26 
Community 
sample 
 
 
 
% 
Mueller et 
al., (2008) 
 
N=31
1
, 29
2
 
Community 
sample 
 
 
 
% 
Affective disorders           
Major depressive disorder 33 25 50 61 45 8 20 62 27 58, 59 
Dysthymia 33 - - - - 12 12 5 15 - 
Bipolar disorder 33 35 - - - - - - - - 
Somatisation disorder 33 - - - - - - - - - 
Body dysmorphic disorder - - - - - - - 3 - - 
Any lifetime affective disorder - 95 - 64  - - -  - 
Anxiety disorders           
Obsessive-compulsive 
disorder 
33 35 - 3 12 - - 13 - 26, 32 
Panic disorder 33 50 10 - - - - 26 - - 
PTSD - - - - - 4 4 13 - - 
Simple phobia - 20 40 - - - - - - - 
Specific phobia - - - - - - - 21 - - 
Agoraphobia - - - - - 8 - - - - 
Generalised anxiety disorder - 30 10 - - 21 - - - - 
Social phobia - 30 - 9 10 - 5 8 15 - 
Any lifetime anxiety disorder -  - 42 - - - 5 - 81, 70 
Eating disorders           
Anorexia nervosa - 20 10 - - - - - - - 
Bulimia nervosa 33 25 10 - 10 8 - 3 - - 
Any lifetime eating disorder -  - 15 - - - 15 - - 
Substance use disorders           
Alcohol abuse/dependence - 35 40 18 14 - - 33 - - 
Other substance 
abuse/dependence 
- 20 - - - - - - - - 
                                            
1 CBT treatment group 
2
 Waiting list control (WLC) group 
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Any abuse/dependence - 40 - 21 - - - - - - 
Impulse control disorders           
Intermittent explosive disorder - 10 - - - - - - - - 
Kleptomania - 10 - - - - - - - - 
Compulsive hoarding  - - - - - - - - - - 
Pathological gambling - 5 10 - - - 5 - - - 
Pyromania - 10 - - - - - - - - 
Trichotillomania - 10 - - - - 5 - - - 
Paraphilia/sexual addictions - 10 - - - - - - - - 
Attention deficit disorders           
Attention deficit disorder - - 10 - - - - - - - 
 
Table 1 continued 
Non-treatment studies 
Diagnosis Christenson 
et al.,(1994) 
 
N=24 
Community 
sample 
 
 
 
% 
Frost et al., 
(2009) 
 
N=653 
Community 
sample 
 
 
 
% 
Mitchell 
et al., (2002) 
 
N= 19 
Community 
sample 
 
 
 
% 
Mueller et al., 
(2007) 
 
N=38
3
,39
4
 
Community 
sample 
 
 
 
% 
Mueller et 
al., (2009) 
 
N= 105 
Community 
sample 
 
 
 
% 
Schlosser 
et al., (1994) 
 
N=46  
Community 
sample 
 
 
 
% 
Affective disorders       
Major depressive disorder 50 - 53 45, 62 - 28 
Dysthymia 17 - - - - - 
Bipolar disorder - - - - - - 
Somatisation disorder - - - - - - 
Body dysmorphic disorder - - - - - - 
                                            
3
 German outpatient sample 
4
 USA outpatient sample 
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Any lifetime affective disorder - - 58 76,62 - - 
Anxiety disorders       
Obsessive-compulsive 
disorder 
13 - 16 - - 4 
Panic disorder 13 - - - - 17 
PTSD - - - - - - 
Simple phobia 17 - - - - 28 
Specific phobia - - - - - - 
Agoraphobia - - - - - - 
Generalised anxiety disorder 21 - - - - 30 
Social phobia 21 - 16 - - - 
Any lifetime anxiety disorder - - 53 - - - 
Eating disorders       
Anorexia nervosa - - - - - - 
Bulimia nervosa 13 - - 18,15 - 17 
Any lifetime eating disorder - - 5 26,15 - - 
Substance use disorders       
Alcohol abuse/dependence 46 - 47 18, 33 - 28 
Other substance 
abuse/dependence 
- - - - - 13 
Any abuse/dependence 46 - 53 24,49 - 30 
Impulse control disorders       
Intermittent explosive disorder 4 - - - - 22 
Kleptomania 4 - - - - 37 
Compulsive hoarding  - 61 - 61 39 - 
Pathological gambling 8 - - - - 20 
Pyromania - - - - - 2 
Trichotillomania 3 - - - - 11 
Paraphilia/sexual addictions - - - - - 13 
Attention deficit disorders       
Attention deficit disorder - - - - - - 
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9. Compulsive buying and compulsive hoarding  
A number of studies have found an association between participant scores on 
clinical measures of CB and compulsive hoarding (e.g. Frost & Gross, 1993; 
Frost, Kim, Morris Bloss, Murray Close & Skeketee, 1998; Frost, Steketee & 
Williams, 2002). Table 1 displays reported data for individuals with CB and co-
morbid lifetime psychiatric illnesses, including compulsive hoarding.  Mueller, 
Mitchell, Crosby, Glaesmer & de Zwann, (2009) report a German population-
based sample (n=2,307), in which around 40% of those with compulsive buying 
also reported co-morbid compulsive hoarding behaviours. Recent research 
suggests that the presence of CB symptomology is associated with greater 
severity of hoarding behaviour and social impairment (Frost, Tolin, Steketee, 
Fitch & Selbo-Burns, 2009; Mueller et al., 2007).  
  
It has been suggested that compulsive buying could be nested within the 
broader construct of „compulsive acquisition‟ (Mueller, Mueller, Albert, Mertens, 
Silbermann, Mitchell, & de Zwann, 2007).  Compulsive „acquisition‟ (as seen in 
hoarding behaviour) involves buying items, picking up free things (including 
objects discarded by others) as well as saving objects or possessions typically 
perceived as useless of limited value. Our understanding of the relationship 
between compulsive buying and compulsive hoarding is in its infancy, and 
represents an important area of future research (Mueller et al., 2007). 
Efficacious treatments for compulsive buying may also be beneficial in the 
treatment of compulsive hoarding symptoms, and this will have important 
implications for our understanding of both disorders.   
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10. Summary 
Current empirical evidence surrounding the aetiology of compulsive buying 
behaviour has been described. Whether CB is best understood as an impulse 
control disorder (ICD), on the obsessive compulsive disorder (OCD) spectrum 
or both; remains open to debate. Recent research suggests that CB is a 
disorder with biological, psychological, and social underpinnings, and theoretical 
integration and synthesis of common factors involved in CB is needed for 
research to progress. CB is a disorder which frequently shares significant co-
morbidity with other psychiatric disorders, particularly compulsive hoarding.       
Over recent years, there has been a growth in the development and treatments 
for CB. Studies have primarily implemented various pharmacological treatments 
(including fluvoxamine, naltrexone, and citalopram), with mixed outcomes. The 
last 10-years have seen increased focus on psychological modalities, 
specifically cognitive-behavioural and family therapies. This review will now 
examine and critically evaluate the CB outcome literature. Table 2 summarises 
the published CB outcome studies, described in the current review. Effect size 
calculations were calculated (Table 3) for those CB treatment studies reporting 
pre-post outcomes. An effect size of 0.8 or above is considered large; 0.5 
medium and 0.2 small.  For some outcome studies, missing results did not allow 
effect size calculations to be calculated and therefore only partial data is 
included. 
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Table 2. Summary of pharmacological, combined and psychotherapeutic treatment studies  
Pharmacological studies 
 
 
Author Sample size and 
recruitment method 
Inclusion/exclusion criteria 
and co-morbidity 
Diagnosis of CB Methodology and 
treatment 
Measures Outcomes 
McElroy et al., (1991) N= 3 females (aged 33-
45 years) with self 
reported problematic 
CB ranging from 8 
months – 5 years 
 
Outpatient sample 
 
Patients met DSM-II-R 
criteria for ICD-not otherwise 
specified 
 
No exclusion criteria 
 
Co-morbidity present in 
sample 
DSM-II-R criteria for 
„impulse control 
disorder – not 
otherwise specified‟ 
(APA, 1987) 
 
Patient self-report of 
CB symptoms 
Case reports 
 
Case1: Treatment with 
fluoxetine  
Case 2:  Treated with 
buproprion; nortryptiline 
and fluoxetine  
Case 3: Treated with 
fluoxetine 
Patient self-report of 
reduction in CB only 
Case1: Treatment with 
fluoxetine (40mg/d) 
resulted in remission of 
CB in 4-6 weeks; 
fluoxetine 40mg/d with 
clonazapam resulted in 
further CB symptom 
remission during 14-
month follow-up 
 
Case 2:  Buproprion (up 
to 100 mg/d) led to 
reduction in depression 
and CB, maintained for 
3-wks. Nortriptyline 
(100mg/d) substituted 
for buproprion due to 
side effects – rapid 
relief in CB. 
Nortryptiline substituted 
for fluoxetine (20mg/d) 
due to side effects – 
combined with 
citalopram (1.5mg/d) 
resultant remission of 
CB maintained at 4 
month follow-up 
 
Case 3: Treated with 
fluoxetine (70mg/d) 
resultant reduction in 
CB symptoms after 1-
week, after 3 further 
  
16 
weeks of treatment CB 
significantly improved 
but not in remission  
Black et al., (1997) 10-non depressed 
compulsive buyers (9 
female; 1 male mean  
 
 
 
 
 
age 41.4 years) 
 
Word of mouth 
recruitment 
Individuals with current 
clinical depression excluded 
 
 
 
 
 
 
Other psychiatric co-
morbidity present in sample 
McElroy et al., (1994); 
Faber & O‟Guinn 
(1992) diagnostic  
 
 
 
 
 
criteria 
 
CB behaviour present 
for 1-year or longer 
9-week open-label trial 
of fluvoxamine 
Baseline and treatment 
termination (9 weeks 
measures): 
 
 
 
 
 
Compulsive Buying 
Scale (CBS) (Faber & 
O‟Guinn, 1992) 
 
Yale Brown Obsessive 
Compulsive Scale-
Shopping Version 
YBOCS-SV (Monahan, 
Black & Gabel, 1996) 
 
National Institute of 
Mental Health 
Obsessive Compulsive 
Scale NIMHOCS 
(Insel, Murphy, Cohen 
et al., (1983) 
 
3 Clinical Global 
Impression (CGI) 
ratings (Guy, 1976) 
 
Patient Self Rating 
Scale (Sheenan, 1986) 
Between baseline and 
treatment termination 
(week 9); 9 out of 10  
 
 
 
 
 
participants showed 
statistically significant 
improvements on all 
measures 
3 out of 10 participants 
lost to 13-week follow-
up. 
7 participants remaining 
at follow-up   
Black et al.,  (2000) 23 participants (22 
females, 1 male; mean 
age 42 years) 
 
Word of mouth 
recruitment 
 
 
 
Individuals with co-morbid 
mood, anxiety or significant 
mental health disorders and 
individuals undergoing active 
psychotherapy excluded  
McElroy et al., (1994); 
Faber & O‟Guinn, 
(1992) 
 
CB symptoms of 1-
year or longer duration 
 
 
Fluvoxamine versus 
placebo in 9-week open 
label trial 
Baseline and end of 
treatment measures 
(week 9): 
 
YBOCS-SV (Monahan, 
Black & Gabel, 1996) 
 
NIMHOCS (Insel, 
Murphy, Cohen et al., 
(1983) 
 
Hamilton Rating Scale 
for Depression (HRD) 
(Hamilton, 1967) 
Failure to demonstrate 
a fluvoxamine treatment 
effect 
 
No significant 
differences between 
fluvoxamine and 
placebo treated 
participants on any 
outcome measures 
except MOI (greater 
improvements in 
fluvoxamine treated 
group) 
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Maudsley Obsessive 
Compulsive Inventory 
(Hodgson & Rachman, 
1977) 
 
Sheenan Disability 
Scale (Sheenan, 1986) 
 
Self report of CB 
symptoms 
 
 
 
 
 
 
 
 
 
 
Ninan et al., (2000)  
 
 
42 patients 
34 (81%) female (aged 
between 18-65 years) 
23 completed the study 
 
Clinical referral and 
media advertisments 
 
 
Individuals with lifetime 
history of psychosis, 
hypomania, current suicide 
ideation, unstable medical 
conditions, pregnancy 
excluded 
 
Other co-morbid disorders 
present in sample 
 
 
CB symptoms 
screened over 
telephone using 
Structured Clinical 
Interview for DSM-IV 
 
 
 
13-week double-blind 
fluvoxamine or placebo 
treatment 
 
 
Baseline and 13-week 
outcome measures: 
 
YBOCS-SV (Monahan, 
Black & Gabel, 1996) 
 
CGI (Guy, 1976) 
 
Global Assessment of 
Functioning (APA, 
1994) 
 
HRD (Hamilton, 1967) 
 
Daily self-report/diaries 
of shopping habits 
 
 
Failure to demonstrate 
a fluvoxamine treatment 
effect when compared 
to placebo 
 
No significant 
differences found 
between fluvoxamine 
and placebo groups on 
any measure of 
outcome. High placebo 
rate observed 
 
Koran et al., (2002) 24 participants 
(22 females, 2 males) 
 
Media advertisment 
Exclusion criteria: 
Co-morbid organic or 
psychotic mental disorders, 
learning disabilities, OCD, 
bipolar disorder, factitious 
disorders, dissociative 
disorders substance abuse 
or individuals wishing to or 
receiving psychotherapy  
 
Other co-morbid psychiatric 
McElroy et al., (1994) 
 
Problematic shopping 
behaviour for 1-year or 
longer 
 
Report shopping 
episodes of at least 
once-per week over 
last 3-months 
7-week open label trial 
followed by 9-week 
double-blind placebo 
controlled 
discontinuation trial of 
citalopram 
YBOCS-SV (Monahan, 
Black & Gabel, 1996) 
 
CGI (Guy, 1976) 
 
Patient global 
Improvement Rating 
(Hamilton, 1967) 
 
Montgomery-Asberg 
Depression Rating 
50% showed 
improvement in CB 
symptoms with mean 
daily dosage of 21.4mg 
of citalopram by week 
two.  
 
38% of participants had 
end-of treatment 
YBOCS-SV scores of 0, 
21% had scores of 4 or 
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disorders present in sample Scale (MADRS) 
(Montomery & Asberg, 
1979) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
less. 54% of 
participants rated CGI 
scores as „very much‟ 
improved or „much 
improved‟ (17%). 
 
3 participants symptom 
free without citalopram 
for 5 months; 7 
experienced relapse in 
CB symptoms. Four of 
7 individuals restarting  
 
 
 
 
citalopram regained 
control of CB 
symptoms. 
 
 
 
 
 
 
 
 
 
Koran et al., (2003) 24 participants 
(23 females and 1 
male) 
 
Media advertisment 
Exclusion criteria: 
Co-morbid organic or 
psychotic mental disorders, 
learning disabilities, OCD, 
bipolar disorder, factitious 
disorders, dissociative 
disorders substance abuse 
or individuals wishing to or 
receiving psychotherapy  
 
 
Co-morbid psychiatric 
disorders present in sample 
McElroy et al., (1994) 
 
Problematic shopping 
behaviour for 1-year or 
longer 
 
Score of 17+ on 
YBOCS-SV (Monahan 
et al., 1996) 
7-week open label trial 
followed by 9-week 
double-blind 
discontinuation trial of 
citalopram over 1-year 
YBOCS-SV (Monahan, 
Black & Gabel, 1996) 
 
CGI (Guy, 1976) 
 
Patient Global 
Improvement Rating 
(Hamilton, 1967) 
MADRS (Montomery & 
Asberg, 1979) 
5 out of 8 individuals 
(63%) in the placebo 
group relapsed 
compared to none of 
individuals who 
continued citalopram 
treatment as usual 
(n=7).  
 
Citalopram treatment 
group rated as „much 
improved‟ or „very much 
improved‟ on the CGI, 
with 50% or greater 
decrease in YBOCS-SV 
scores.  
Koran et al., (2007) 26 women (mean age 
45.1) 
 
Media advertisement 
No individuals to be 
undergoing psychotherapy 
and discontinue all   
psychotropic medications for 
Meet McElroy et 
al.,(1994) CB criteria 
for at least 1 year 
 
Participants were 
started on an open-
label 10mg/d dose of 
Escitalopram, which 
YBOCS-SV (Monahan, 
Black & Gabel, 1996) 
 
CGI (Guy, 1976) 
No differences between 
the escitalopram and 
placebo groups. Six out 
of 9 individuals in the 
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at least 1-week prior to trial 
 
 
Co-morbid psychiatric 
disorders present in sample 
Engage in compulsive 
buying at least once 
per week for the last 6-
months  
 
Score of 17+ on 
YBOCS-SV (Monahan 
et al., 1996) 
was increased to 20 
mg/d after four-weeks 
for non-responders. 
After the first phase of 
the trial (7-weeks), 
treatment responders 
(defined as individuals 
with a CGI score of 
either „very much‟ or 
„much improved‟ and a 
YBOCS-SV score of 
<17 and 50% decrease  
 
 
 
 
 
from baseline) were 
then randomised to 
either 9-weeks of 
escitalopram or 
placebo 
MADRS (Montomery & 
Asberg, 1979) 
placebo group 
relapsed, compared to 
5 of 8 continuing 
escitalopram.  
 
McElroy et al., (1994) Report of 20 CB cases 
 
N=16 females, 4 males 
(mean sample age 39 
years) 
 
Outpatient sample 
Inclusion criteria: 
McElroy et al., (1994) 
Criteria developed: 
Buying described as 
1) Uncontrollable 
2) Significantly 
distressing, time consuming 
or resulting in social or 
financial difficulties 
3) Not occurring in 
the context of hypomanic or 
manic symptoms 
 
Co-morbid psychiatric 
disorders present in sample 
 
 
McElroy et al., (1994) 
criteria developed 
during study 
Treatment with various 
drug combinations (e.g.  
fluoxetine, nortiptyline, 
lithium, buproprion, 
setraline) 
Self reported 
reductions in CB 
symptoms 
9 of 13 patients 
described significant or 
complete reductions in 
buying behaviour in 
response to 
antidepressants 
administered alone or in 
conjunction with mood 
stabilizers 
Grant (2003) 3 females 
Case 1 – 32-year old 
woman 
Case 2 – 43-year old 
male 
Case 3 – 28-year old 
woman   
 
Clinical outpatient 
Cases met CB criteria 
however not reported how 
assessed 
Co-morbidity absent in all 3 
cases 
Not reported Treatment with 
naltrexone (100-200 
mg/d) 
Treatment duration 
between 10-32 weeks 
Unknown Self reported CB 
symptoms showed 
partial or complete 
remission within 1-4 
weeks in all cases 
 
Relapse in CB 
symptoms when 
naltrexone was 
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Combined treatment studies 
 
Author Sample size and 
recruitment method 
Inclusion /exclusion 
criteria and co-morbidity 
Diagnosis of CB Methodology and 
treatment 
Measures Outcomes 
Bernik et al., 
(1996) 
2 separate N=1 case 
studies 
Patient 1 – 31-year old 
woman 
Patient 2 – 34-year old 
woman 
 
Clinical patient recruitment 
Co-morbid psychiatric 
disorders present in both 
cases 
Self-report only Behavioural treatment 
Exposure and response 
prevention 
Not reported Authors report both cases 
demonstrated either a complete 
remission or complete control 
over their CB in 3-4 weeks. 
Markinko & 
Karlovic (2005) 
Case study N=1 
32-year old female 
 
Clinical patient recruitment 
Co-morbidity not reported Self-report only Treated with combination 
of fluvoxamine and 
individual cognitive 
behavioural therapy 
Not reported Authors report complete 
remission of CB symptoms 
following treatment which was 
maintained at 12-month follow-up 
 
 
 
referral  withdrawn; control of 
CB symptoms regained 
in all 3 cases between 
8-32 weeks following 
re-administration of 
naltrexone. 
Guzman et al., (2007) 1 female patient aged 
37-years 
 
Clinical outpatient 
referral 
Co-morbid psychiatric 
disorder in case 
Not reported Case report 
 
Outpatient treatment 
 
Participant treated with 
topiramate (50mg/d)  
 
 
 
 
 
 
combined with 
venlafaxine (225mg/d) 
over 1 month) 
Beck Depression 
Inventory (BDI) (Beck, 
Steer & Brown, 1995) 
After beginning 
topiramate, authors 
report CB „subsided‟ 
and depression 
„remitted‟. 
  
21 
Psychotherapeutic studies 
 
Author Sample size and method Inclusion /exclusion 
criteria and co-morbidity 
Diagnosis of CB Methodology and 
treatment 
Measures Outcomes 
Kellett & 
Robinson (2009)  
Case study N=1 
40-year old female 
 
Clinical patient recruitment 
Faber & O‟Guinn, (1992) CB 
criteria 
 
Co-morbidity reported absent 
in case 
Faber & O‟Guinn, (1992) criteria Single-case experimental 
design (SCED) A,B,C 
plus follow-up. 
 
CBT (phase B) Person 
Centred Counselling 
treatment (phase C) 
CBS (Frost et al., 
1998) 
 
YBOCS-SV 
(Monahan et al., 
1996) 
 
 
Brief Symptom 
Inventory 
(BSI)(Derogatis, 
1993) 
 
BDI (Beck, Steer 
& Brown, 1995) 
 
Inventory of 
Interpersonal 
Problems-32 
(IIP-32 
(Barkham, Hardy 
& Startup, 1996) 
 
At end of treatment client no 
longer met criteria for CB; 
progress which was maintained 
over follow-up 
Kellett & Bolton 
(2009) 
N =1 case study 
36-year old female 
 
Clinical patient recruitment 
Faber & O‟Guinn, (1992) 
criteria 
 
Co-morbidity not reported by 
authors 
Faber & O‟Guinn, (1992) criteria Cognitive behavioural 
therapy 
14, 50-minute outpatient 
sessions (three 
assessment sessions, 10 
intervention sessions, 
one follow-up session 6-
months post intervention) 
CBS (Frost et al., 
1998) 
 
YBOCS-SV 
(Monahan et al., 
1996) 
 
 
BSI (Derogatis, 
1993) 
 
BDI (Beck, Steer 
& Brown, 1995) 
 
IIP-32 (Barkham, 
Hardy & Startup, 
1996) 
 
At end of treatment client no 
longer met criteria for CB; 
progress which was maintained 
over follow-up 
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Mitchell et al., 
(2006) 
28 females 
 
Recruited via media 
advertisement 
Individuals with current or 
previous psychiatric histories 
were excluded; as were 
participants receiving 
psychotherapy treatment 
 
Co-morbid psychiatric 
disorders present in sample 
Faber & O‟Guinn, (1992) Allocation to 1 of 4 CBT 
group therapy treatment 
groups, n=11 allocated to 
waiting list control 
 
Therapy conducted via 
12, 1.5 hour group 
therapy sessions over 
10-weeks  
 
CBT groups 
assessed at 
baseline, end of 
treatment (10-
weeks) and 6-
month follow-up. 
Individuals on 
waiting list 
control 
reassessed at 3-
months. 
 
CBS (Faber & 
O‟Guinn, 1992) 
 
YBOCS-SV 
(Monahan et al., 
1996) 
 
BDI (Beck et al., 
2006) 
 
Four week 
purchasing recall 
(Burgard et al., 
2006) 
 
Outcomes Study 
Short form 36 
(Ware et 
al.,1993)  
 
 
Baseline comparisons showed 
significant improvement in all 
measures. 
Large effects sizes notes on the 
CBS, YBOCS-SV and 4-week 
purchasing recall, with 
improvements maintained at 6-
month follow up 
 
10 participants reported 
complete remission of CB 
episodes during previous 4-
weeks compared to none of 
participants in waiting list control 
 
 
 
 
 
 
Mueller et  
al.,(2008) 
 
 
 
 
 
 
31 participants 
Mean age 41 years 
 
Recruited via media 
advertisement 
 
 
 
 
 
 
Exclusion criteria: 
Individuals with active 
suicidal ideation, mania  
 
Individuals could be on anti-
depressants in on stable 
dose for 3 months or longer; 
 
Individuals could be receiving 
 
 
 
 
 
 
McElroy et al., (1994) 
 
 
 
 
 
 
Randomized controlled 
trial comparing Burgard 
et al’s., (2006) group CBT 
treatment programme 
with waiting list control  
 
 
 
 
 
 
CBS (Faber & 
O‟Guinn, 1992) 
 
YBOCS-SV 
(Monahan et al., 
1996) 
 
SCL-90 (Franke, 
1995) 
 
 
 
 
 
 
N=24 available for follow-up. 
 
Significant differences between 
the CBT and waiting list control 
groups on CBS, YBOCS-SV and 
CBS with significant 
improvements in CBT group 
which were maintained at 6-
month follow-up. 
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psychotherapy if began 
treatment 6 months 
previously 
 
Co-morbid psychiatric 
disorders present in sample 
 
 
Barratt 
Impulsiveness 
Scale (Patton, 
Stanford & 
Barratt, 1995) 
 
Saving Inventory 
Revised (Frost, 
Steketee & 
Grisham, 2004) 
 
CBT treatment did not have 
impact on SCL-90-R, BIS or SI-R 
scores. 
 
Higher rates of pre-treatment 
hoarding significant predictors of 
non-remission of CB symptoms 
and poor treatment attendance.  
Park et al., 
(2006) 
N=1 
Family therapy treatment of 
24-year old female with CB 
 
Recruitment method not 
reported 
Inclusion/exclusion criteria 
not reported 
 
Co-morbidity not reported 
Not reported Fifteen family therapy 
sessions (individual, 
parental, family and 
telephone based 
sessions) 
 
Sessions taped/video 
recorded and analysed 
qualitatively using 
grounded theory (Glaser 
& Strauss, 1967; Strauss 
& Corbin, 1998) 
Not reported 6 key factors related to CB 
(communication issues with 
family members; sibling 
relationships; mothers parenting 
and communication style, 
interpersonal relationships and 
stress. 
 
Change in CB behaviour 
attributed to better 
communication with family; 
development of close sibling 
relationship; change in mother‟s 
parenting style and 
communication; positive 
interpersonal relationships and 
decreased family stressors. 
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Table 3. Published outcome data of treatment studies in compulsive buying 
 
CB treatment studies 
 
Patients (n=) Outcome measure Pre Post Effect size 
Black et al., (1997) (n=10) YBOCS-SV 21.1 12.0 2.02 
Koran et al., (2002) (n=24) YBOCS-SV 22.6 7.2 1.62 
Koran et al., (2003) (n=24) YBOCS-SV 24.4 8.2 1.98 
Guzman et al., (2007) (n=1) BDI-II 26/63 n/a n/a 
Kellett & Robinson (2009) (n=1) CBS -2.87 3.27 n/a 
Kellett & Bolton (2009) (n=1) YBOCS-SV 19.00 11.00 3.2 
Mitchell et al., (2006) (n=28) YBOCS-SV 
 
22.6 6.4 
 
2.19 
Mueller et al., (2008) (n=24) YBOCS-SV 20.7 13 0.88 
Bernik et al., (1996) (n=2) n/a n/a n/a n/a 
Grant (2003) (n=3) n/a n/a n/a n/a 
Markinko & Karlovik 
(2005) 
(n=1) n/a n/a n/a n/a 
McElroy et al., (1991) (n=3) n/a n/a n/a n/a 
McElroy et al., (1994) (n=20) n/a n/a n/a n/a 
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11. PHARMACOTHERAPY TREATMENT 
By far the largest area of research focused on treatments for compulsive buying 
have been pharmacological, including treatment with a range anti-depressants 
(administered alone or in combination (e.g. Black, Monahan & Gabel, 1997; 
McElroy, Satlin, Pope, Keck & Hudson, 1991); opioid agonists (e.g. naltrexone – 
Grant, 2003) and anti-convulsants (e.g. Guzman, Filomensky & Taveres, 2007). 
 
11.1. Anti-depressant treatment 
McElroy, Satlin, Pope, Keck and Hudson, (1991) reported outcomes of three 
female cases of CB treated with antidepressants (fluoxetine, buproprion or 
nortryptiline). All patients met DSM-II-R criteria for an „impulse control disorder - 
not otherwise specified‟ (APA, 1987) had histories of problematic buying 
behaviour ranging from 8 months to 5 years and presented with co-morbid 
mood and anxiety disorders. The findings indicated that within 4 weeks of 
treatment, all three cases showed a partial or complete remission in urges to 
buy, which was comparable amongst the different antidepressants used. 
 
11.2. Critique of study 
A number of limitations exist with this study. Firstly, no control or comparison 
groups were used, making it difficult to draw firm conclusions about treatment 
efficacy. It is possible, for example, that the improvements in CB symptoms 
were a function of a „placebo‟ effect, or indeed increased therapist contact and 
support.  The small sample size, consisting of all women limits the 
generalisability of the findings and would need to be replicated in a much larger 
sample. High levels of co-morbidity were present in the cases treated. It 
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therefore cannot be ruled out that treatment was in fact targeting anxiety or 
depression, rather than CB symptoms as assumed. CB was not measured or 
assessed formally, other than via narrative self-reports, and no statistical 
analysis of outcomes were performed, making it particularly difficult to evaluate 
the level of change in CB symptoms observed. Despite success in reduction of 
CB symptoms in all three cases (partial reduction in one case), the study 
employed a complicated regimen of drug treatments (using different anti-
depressants in each case), and does not give a detailed account of drug 
administration procedures, making it extremely difficult to formally assess a true 
„drug effect‟.   
 
11.3. Fluvoxamine5 treatment 
 
Black, Monahan and Gabel (1997) treated 10 non-depressed compulsive 
buyers in a 9-week open-label trial6 of fluvoxamine. Individuals were required to 
meet both the McElroy et al., (1994) and Faber and O‟Guinn, (1992) diagnostic 
criteria for CB, and display problematic buying behaviour for 1-year or longer. 
The sample comprised 9 women and 1 man with a mean sample age of 41.4 
years.  Between baseline and treatment termination (week 9), 9 out of 10 
participants showed statistically significant improvements on all measures. A 
                                            
5
 Fluvoxamine is an anti-depressant selective-serotonin reuptake inhibitor (SSRI), 
recommended in the management of depression and anxiety disorders (see Figgitt and 
McClellan, 2000 for an overview). 
 
6
 Open label trials are clinical trials in which both the patients and the researcher know which 
treatment is to be administered. Random allocation to treatment groups can be employed but 
not always, which unfortunately means that outcome may be attributable to other factors other 
than treatment administered (e.g. placebo effect, therapist contact) leaving the study 
susceptible to bias. 
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total of 3 out of the original 10 individuals were lost to follow-up at 13-weeks. 
However, all seven participants remaining at 13-week follow-up requested 
continuation of fluvoxamine treatment.   
 
Black, Gabel, Hansen and Schlosser (2000) later compared fluvoxamine to 
placebo treatment, in a subsequent 9-week, open-label trial. The sample (22 
females and 1 male; mean sample age 42 years) were randomly assigned to 
either Fluvoxamine (n=12) or placebo (n=11) treatment conditions. In contrast to 
the earlier Black et al., (1997) study, the findings failed to demonstrate a 
fluvoxamine treatment effect. No significant differences between the 
fluvoxamine and placebo treated participants were apparent on any of the 
outcome measures, other than fluvoxamine treated participants showed greater 
improvements on the MOI (Hodgson & Rachman, 1977).  The study concluded 
that as fluvoxamine and placebo performed similarly, fluvoxamine could not be 
supported as a treatment option for CB. 
 
Ninan, McElroy, Kane, Knight, Bettina, Casuto, Rose, Marsteller and Nemeroff 
(2000) randomly assigned 23 patients to 13-weeks of double-blind fluvoxamine 
or placebo treatment conditions. The sample comprised individuals aged 18 to 
65 years, with symptoms of problem buying behaviour present for 6-months or 
longer. Ninan et al.’s, (2000) findings are comparable to those of Black et al., 
(2000), and found that fluvoxamine was no more effective in treating CB when 
compared to placebo in a 12-week, double blind, controlled trial. No significant 
differences were found between the active treatment or placebo groups on any 
measure of outcome, with a high placebo response rate observed.  
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11.4. Critique of fluvoxamine treatment studies 
The initial positive findings of Black et al., (1997) that fluvoxamine offered a 
useful treatment option for compulsive buying, were not supported by later 
studies carried out by Black and colleagues (2000) and Ninan et al., (2000) in 
trials of fluvoxamine versus placebo. In both cases, fluvoxamine performed 
comparably to placebo. Both studies employed a standardised, reliable and well 
validated measure of compulsive buying (YBOCS-SV, Monahan, Black & 
Gabel, 1996) and conducted statistical analyses of outcome.  Black et al., 
(1997) controlled for co-morbidity in participants, however Ninan et al., (2000) 
did not exclude all co-morbid disorders (e.g. depression/anxiety), which may 
have influenced treatment outcome. The small sample sizes of both studies are 
problematic, and it is it unclear from either study whether any power analysis 
(e.g. Kazdin & Bass, 1989) was undertaken. It may be the case that a failure to 
demonstrate treatment effects is a result of a weakness in statistical power, 
rather than with treatment efficacy.  
 
11.5. Citalopram7 treatment 
 
Koran, Bullock, Hartson, Elliot and D‟Andrea (2002) reported initial findings of a 
12-week, open label trial of citalopram. This study was replicated one-year later 
(Koran, Choung, Bullock and Smith (2003) in a 7-week, open label trial followed 
                                            
7 Citalopram is a selective serotonin reuptake inhibitor (SSRI) frequently used in the treatment 
of depression (see Keller, 2000).  
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by a 9-week double-blind placebo-controlled discontinuation trial of citalopram.   
Participants in both studies were required to meet criteria for CB (McElroy et al., 
1994), have problematic shopping behaviour for at least 1-year and report 
shopping episodes of at least once per-week over last 3 months. A total of 24 
participants (22 women and 2 men) completed the initial (2002) trial, and 24 
participants (23 women and 1 man) completed the later trial. Results of the 
initial (2002) trial demonstrated that a mean daily dosage of 21.4mg of 
citalopram produced a rapid response rate, with 50% showing improvement in 
CB symptoms (interest in shopping, preoccupation with shopping, purchasing) 
by week two. A total of 38% of participants had end-of treatment YBOCS-SV 
scores of 0, and 21% had scores of 4 or less.  In 54% of participants, CGI-I 
scores were „very much improved‟, and in 17% „much improved‟. 
Longer-term, three individuals remained symptom free without citalopram for a 
total of 5 months, whilst 7 individuals experienced a relapse in CB symptoms. 
Four of these 7 individuals who restarted citalopram treatment as a result, 
regained control over their CB symptoms. Despite positive outcomes, the 
authors speculated that the completion of shopping logs/diaries and therapist 
contact throughout the trial may have accounted for changes in symptoms (i.e. 
as a therapeutic effect). Furthermore, the lack of placebo comparison group 
prevented the examination of whether changes observed were in fact due to a 
placebo response.  
 
In order to counter some of these initial methodological weaknesses, Koran, 
Choung, Bullock and Smith (2003)  conducted a 7-week, open label trial 
followed by a 9-week double-blind placebo-controlled discontinuation trial of 
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citalopram over a period of one-year. All of the participants (n=24) initially 
received 20mg/d doses of citalopram, which was gradually increased over a 
period of two-weeks to 60mg/d, for a total of 7 weeks. Those who responded to 
citalopram at the end of the 7-week period (n=15) were then randomised to 
either 9-weeks of double-blind citalopram (n=7) or placebo (n=8) treatment. 
Koran et al. (2003) report 5 out of 8 (63%) individuals in the placebo group 
relapsed, compared to none of individuals who continued with citalopram 
treatment as usual (n=7). Those in the citalopram treatment group were rated 
“much improved” or “very much improved” on the CGI and had a 50% or greater 
decrease in YBOCS-SV scores. In this study, citalopram appeared to be an 
effective method of treatment for compulsive buying symptoms when compared 
to placebo in a double-blind trial. 
 
11.6. Critique of citalopram treatment studies 
The results of the Koran et al., (2003) study demonstrate that citalopram seems 
to offer a useful treatment option for CB.  
The sample selection represents one of the main weaknesses of both studies 
as both employed opportunistic sampling via media advertisements. Samples 
obtained in this way may differ to clinical populations in terms of clinical 
presentation of CB and treatment motivation. Furthermore, although both 
studies did include males in their samples, (which is a strength over many other 
CB treatment studies), the numbers (n=1 and 2) are too small to allow 
generalisability to other males with CB. The small sample more generally (n=24) 
may be problematic and there is no indication of whether power analysis of 
sample size was conducted prior to undertaking statistical analysis.  Despite 
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positive findings of citalopram in the Koran et al., (2003) study, unfortunately no 
long term follow-up data are provided, which prevents any conclusions being 
drawn about the usefulness of this drug treatment over time.  
 
11.7. Escitalopram treatment 
In a methodological replication of the Koran et al., (2003) study, Koran, 
Aboujaoude, Solvason, Gamel and Smith (2007) used the SSRI escitalopram8 
in the treatment of CB. The sample comprised 26 women (mean sample age 
45.1). Participants met CB inclusion criteria outlined by McElroy et al., (1994) 
for at least 1 year, engaged in compulsive buying at least once per week for the 
last 6-months and scored 17 or more on the YBOCS-SV (Monahan et al., 
1996). Participants were started on an open-label 10mg/d dose of Escitalopram, 
which was increased to 20 mg/d after four-weeks for non-responders. After the 
first phase of the trial (7-weeks), individuals who responded to treatment, 
(defined as individuals with a CGI score of either „very much‟ or „much 
improved‟ and a YBOCS-SV score of less than 17 and 50% decrease from 
baseline) were then randomised to either 9-weeks of escitalopram or placebo. 
The study failed to find any differences between the escitalopram and placebo 
groups. Six out of 9 individuals in the placebo group relapsed, compared to 5 of 
8 continuing escitalopram, and a number of participants in both treatment 
groups developed new depressive symptoms.  
 
 
                                            
8 Escitalopram is an anti-depressant selective serotonin reuptake inhibitor (SSRI). It is 
recommended in the treatment of depression, Generalised anxiety disorder, panic disorder and 
social anxiety (see Cipriani, Furokawa, Salanti & Geddes, 2009).  
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11.8. Critique of study 
This study has several methodological limitations. Of the 295 original enquiries 
to take part in the study, only 26 completed the trial (all of which were female), 
indicating a high drop-out rate. It may be the case that those individuals who 
chose to participate differed in important ways to those that did not (e.g. severity 
of CB symptoms). Furthermore, individuals with co-morbid diagnoses were not 
excluded, making it difficult to ascertain which were the primary symptoms 
being treated by escitilopram. The small sample size and lack of males limits 
the generalisability of the findings. Further, reliance on media advertisements 
increases the risk that the sample may differ from clinical samples with CB.  
 
11.9. Mixed pharmacological treatments 
McElroy, Keck, Pope, Smith and Strakowsi (1994) reported findings from the 
treatment of 20 patients with problematic buying behaviour. Patients were 
required to meet three compulsive buying criteria; (1) CB expressed as 
„uncontrollable‟, (2) time-consuming and (3) a cause of social or financial 
difficulties. A total of 16 females and 4 males participated. A wide range of 
mood stabilizers (including lithium and valproate and antipsychotics) and 
antidepressants (including nortryptiline, fluoxetine, setraline and trazedone) 
were used alone or in combination. Complete or partial remission was observed 
in 55% or cases over a period ranging from 2 weeks to 13 months. 
 
11.10. Critique of study 
Despite the CB diagnostic tool developed as part of this study being 
subsequently widely used (e.g. Black, Monahan & Gabel, 1997; Koran, Bullock, 
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Hartson, Elliott & D‟Andrea, 2002), the study does have methodological 
limitations. The diagnosis of CB is based on only three factors, and lacks 
adequate reliability/validity data, making it particularly difficult to establish 
severity and variability in CB symptoms or evaluate clinically significant change. 
Several other limitations exist. The study lacked any control or comparison 
groups, and did not employ randomisation. The unsystematic administration of 
drug treatments make it particularly difficult to establish which drug (or 
combination of drugs) could be responsible for the improvements in symptoms. 
High levels of co-morbidity were observed in the sample, and the sample lacked 
homogeneity in reported CB symptoms. Nine participants were also receiving 
psychotherapy during treatment, which may have been the overall mechanism 
of change in CB symptoms. No statistical analysis or data were presented 
relating to the outcomes of the study, making it difficult to draw conclusions 
around the clinical significance of the changes observed in some of the 
participants. Furthermore, a lack of follow-up data negates any opportunity to 
examine the long-term effectiveness of the treatment, in those participants who 
reported remission in compulsive buying symptoms. 
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11.11. Naltrexone9 treatment 
Grant, (2003) described three cases of CB treated with naltrexone (100-200 mg 
daily). Two females (aged 28 and 32 years old) and one male (aged 43 years 
old) completed treatment over a period ranging between 10-32 weeks. Duration 
of CB ranged from 2-9 years across the cases. In all 3 participants, a partial or 
complete remission of CB symptoms (e.g. self reported urge to shop) was 
reported within 1-4 weeks following commencement of Naltrexone (up to 
maximum dose of 200mg/d in one case). All participants reported a relapse in 
CB symptoms on Nalrexone withdrawal. Longer-term, the author reports that 
when Naltrexone treatment was re-administered, control of CB symptoms was 
observed in all three cases up to between 8 and 32 weeks.  
 
11.12. Critique of study 
In this case, treatment with naltrexone appeared to produce rapid results in the 
alleviation of CB symptoms. However, the study has a number of clear 
limitations. The sample size is particularly small (n=3), and it is unclear how the 
sample were selected, nor which specific diagnostic criteria were used in the 
diagnosis of CB, limiting the generalisability of the findings. There was no long 
term follow-up, nor any relevant outcome data other than self-reported „urge to 
shop‟, making it hard to assess the long-term effectiveness of the method of 
treatment. No randomisation was employed; making it possible that outcome is 
attributable to placebo effect.  
                                            
9 Naltrexone is an opioid antagonist. It is typically used the treatment of alcohol and drug 
dependence, but also has also been examined as a treatment of a variety of psychiatric 
disorders including self-harm (see Modesto-Lowe & Van-Kirk, 2002 for a review of treatment 
applications of Naltrexone).  
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11.13. Topiramate10 treatment  
Guzman, Filomensky and Taveres (2007) provide a case report of a 37 year-old 
woman with CB treated with topiramate. The patient was receiving outpatient 
treatment for CB and depressive disorder, which had previously been 
unsuccessfully treated with fluoxetine. The patient reported that CB onset was 
around 3-years prior to treatment, with CB taking up at least 10 hours a day.  
The study reports that the patient was originally treated with venlafaxine up to 
225mg/d, which after 3 months demonstrated no reduction in CB or depressive 
symptoms. Topiramate was then added (50mg/d up to 150mg/d within 1 
month). The authors report that one-month after topiramate was added, the 
compulsive shopping „subsided‟, and depression „remitted‟. The venlafaxine 
was then discontinued. 
 
11.14. Critique of study  
There are a number of methodological limitations with this study. Firstly, the 
study is limited by the sample size of a single patient which significantly limits 
the generalisability of the findings to other populations. No statistical analyses 
were conducted, and findings reported are based on self-reported reduction of 
CB and depressive symptoms. Guzman et al., (2007) report using „semi-
structured‟ interviews to assess symptoms, but no details of these were 
provided and it is unclear how compulsive buying was formally diagnosed, or 
                                            
10 Topiramate is an anti-convulsant typically used in the treatment of epilepsy migraine (see 
Vikelis & Rapoport, 2010 for a review). However, it has been investigated in the treatment of 
other clinical disorders, including alcohol dependence (see De Sousa, 2010 for a review), 
kleptomania (e.g. Dannon, 2003) and post-traumatic stress disorder (e.g. Mello, Yeh, Barbosa, 
Braga, Fiks, Mendes, Moriyama, Valente, Costa, Mattos, Bressan, Andreoli, & Mari, 2009).   
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whether diagnosis was based on clinical opinion only. Due to the lack of 
experimental control, it cannot be concluded that topiramate accounted for 
changes in the client‟s self-reported CB behaviour, since no randomisation or 
baseline was employed or established, and the topiramate was administered in 
conjunction with another medication, venlafaxine. Given the significance of the 
methodological problems, and lack of detail given within this report, it is not 
possible to conclude that topiramate could offer a useful treatment option for 
compulsive buying.       
 
12. Summary of pharmacological treatment evidence 
In summary, results of pharmacological treatment studies for CB are mixed. 
Early studies of antidepressant treatments, used alone or in combination with 
other mood stabilizers (e.g. McElroy et al., 1991; McElroy et al., 1994) report 
success in treating CB symptoms. The antidepressant fluvoxamine showed 
benefit in reducing CB symptoms in an open label trial (Black et al., 1997), 
however these findings were not supported by two later trials comparing 
fluvoxamine to placebo (Black et al., 2000; Ninan et al., 2000).  A 12-week open 
label trial of the antidepressant citalopram (Koran et al., 2002) demonstrated 
significant improvements in reduction of CB symptoms, results which were 
confirmed by a 9-week double-blind discontinuation trial of citalopram versus 
placebo (Koran et al., 2003). Grant (2003) describes 3 cases which showed 
improvement in CB symptoms when treated with the opioid antagonist 
naltrexone; whilst Guzman et al., (2007) describe successfully treating CB 
symptoms in one individual with a combination of the anticonvulsant topiramate 
and antidepressant venlafaxine.   
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Methodological limitations across studies; including small sample sizes, reliance 
on non-clinical samples, lack of standardised CB diagnostic criteria employed, 
high rates of co-morbidity, lack of follow-up data and furthermore the non-
systematic implementation of drug treatments in some cases prevents viable 
conclusions being drawn. These methodological limitations need to be 
addressed, using larger randomised controlled trials for future research into 
pharmacological treatments for CB to progress.  
 
13. COMBINED TREATMENTS11 
 
13.1. Case reports 
Bernik, Akerman, Ameral and Braun, (1996) described the treatment of two 
women with CB (both whom presented with co-morbid panic disorder and 
agoraphobia) with fluoxetine. It is reported that both participants demonstrated 
either complete remission or „complete control‟ over their CB in only 3-4 weeks, 
after exposure and response prevention treatment (including visiting places 
where purchasing most likely to occur, touching objects and being prevented 
from buying anything). Although the study provides some very limited 
description of treatment techniques used, it is not to the extent that would allow 
treatment replication. In addition, in the two cases reported, CB does not appear 
to be the primary symptom and there is no way of knowing whether the 
individuals would meet clinical diagnostic criteria for CB, since compulsive 
buying symptoms were only obtained via self-report.   
                                            
11
 Combined treatments refers to studies in which pharmacological and psychotherapeutic 
modalities have been combined as part of CB treatment.  
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Marcinko and Karlovic (2005) described a 32 year-old woman with CB who was 
successfully treated with a combination of fluvoxamine and individual cognitive-
behavioural therapy. Similarly, it is particularly difficult to draw any firm 
conclusions regarding the findings reported in this study, given that it lacked any 
specific detail regarding the cognitive-behavioural techniques used, nor the 
length of treatment. However, the authors report that in this case, complete 
remission of CB episodes was maintained during the 12-month follow-up.       
 
13.2. Critique of case reports      
Both the Bernik et al., (1996) and Markinko & Karlovic (2005) qualitative studies 
are based on either a pair or a single patient and lack adequate sample size.  It 
is unclear how the treatments in either study were delivered, and fidelity to the 
treatment model was not assessed.  The general lack of detail in either study 
negates attempts at replication and prevents conclusions regarding treatment 
effectiveness from being drawn.  
 
13.3. Summary of combined treatments evidence  
As no experimental design was employed in either study, it is not possible to 
examine the exact mechanism of change in the reduction of CB symptoms. At 
the present time the evidence base for combined treatments for CB is 
particularly small and is not methodologically robust enough to draw firm 
conclusions regarding treatment effectiveness.   
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14.  PSYCHOTHERAPEUTIC TREATMENTS 
 
14.1. Cognitive-Behavioural Therapy 
In recent years, there has been an increased focus in the application of 
psychological modalities of treatment for CB, particularly cognitive-behaviour 
therapy (CBT)12.  
 
14.2. CBT case reports  
Two case reports provide evidence for CBT treatment of compulsive buying 
behaviour.  
Kellett and Bolton (2009) report a case study detailing the application of their 
cognitive-behavioural treatment model, with a 36 year old female client meeting 
Faber & O‟Guinn, (1992) CB criteria. The client completed fourteen 50-minute 
out-patient sessions (three assessment sessions, 10 intervention sessions, and 
one follow up session 6-months post-intervention). By session 10, a mutual 
decision to discontinue therapy was agreed, due to the client reporting control of 
CB symptoms. At the end of treatment, the client no longer met criteria for CB 
(Faber & O‟Guinn, 1992), and made further progress over the follow-up period. 
Reliable improvements in shopping behaviours (as measured on the CAS and 
                                            
12 Cognitive behaviour therapy is a therapeutic approach which aims to understand problems in terms of 
the relationship between thoughts, feelings and behaviours. In the United Kingdom, it is widely 
acknowledged as the treatment of choice for a range of emotional and psychiatric disorders, including 
depression, anxiety and obsessive compulsive disorder (see National Institute for Clinical Excellence 
(NICE) www.nice.org.uk website for full guidance. 
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YBOC-SV), and mental health (measured by the BDI-II and BSI) were also 
demonstrated at termination of treatment and 6-month follow-up. 
 
Kellett and Robinson (2009) describe an ABC plus follow-up single case 
experimental design (SCED) of the treatment of a 40-year old woman referred 
for treatment of CB. The patient was treated using a combination of cognitive-
behavioural therapy (treatment phase B) including exposure and response 
prevention and cognitive challenge; in addition to person-centred counselling 
(treatment phase C) over a total period of 23 sessions (assessment phase A = 
3 sessions, treatment phase B = 13 sessions, treatment phase C = 6 sessions, 
follow-up phase FU = 1 session). Reliable reductions were observed across the 
range of outcome measures including the Beck Depression Inventory (BDI-II: 
Beck, Steer and Brown, 1995); Brief Symptom Inventory (BSI: Derogatis, 1987); 
Inventory of Interpersonal Problems (IIP-32: Barkham, Hardy & Startup, 1996); 
Compulsive Buying Scale (CBS: Faber & O‟Guinn, 1992); YBOCS-SV 
(Monahan et al., 1996) and Compulsive Acquisition Scale (CAS: Frost et al., 
1998); psychometric gains were maintained at follow-up.  Outcome graphs of 
the experimental measures showed demonstrable reductions in shopping and 
obsessions and an improved sense of self over the phases of the study.  
 
14.3. Critique of CBT case reports 
The small sample size (n=1) in both Kellett & Bolton (2009) and Kellett & 
Robinson (2009) studies limits the extent to which treatment outcomes can be 
generalised to other individuals with CB. However, the use of outcome 
measures is an improvement on earlier case studies outlined (e.g. Bernik et al., 
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1996; Markinko & Karlovic, 2005), as is the use of single case experimental 
design (SCED),  as it allows symptom change to be clearly delineated. 
However, due to the nature of standard clinical practice, the likelihood of 
demand characteristics (e.g. client trying to „please‟ the therapist) may have 
influenced the overall outcome. Both studies indicate long-term outcomes of 
through gathering follow-up data, which has been lacking in extant CB case 
studies of this type.  
 
14.4. Group cognitive-behavioural therapy  
 
Mitchell, Burgard, Faber, Crosby and de Zwann, (2006) evaluated a manualised 
group CBT programme for CB (Mitchell & Burgard, 2000), compared to waiting-
list control. A total of 39 women, who scored two or more standard deviations 
above the mean on the Compulsive Buying Scale (Faber & O‟Guinn, 1992), 
participated. Twenty-eight (n=28) women were allocated to one of four CBT 
treatment groups. Eleven (n=11) were assigned to waiting list control. Therapy 
was conducted via 12, 1.5 hour sessions over 10-weeks. Twenty-one 
participants completed the treatment in full. Baseline comparisons showed 
significant improvement in all measures with large effect sizes noted on the 
CBS, YBOCS-SV and 4-week purchasing recall measure, with improvements 
maintained at 6-month follow-up. At follow-up, 10 participants reported a 
complete remission of CB episodes during the previous 4-weeks, compared to 
none of the participants assigned to the waiting list control.  
In conclusion, this study has demonstrated a promising method of treatment for 
compulsive buying, with effects maintained at 6-month follow-up. 
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Mueller, Mueller, Silbermann, Reinecker, Bleich, Mitchell and de Zwann (2008) 
similarly compared the efficacy of Burgard & Mitchell‟s (2000) group programme 
versus waiting list control (WLC). Thirty-one participants who met McElroy et al., 
(1994) CB criteria took part (mean sample age 41.3 years).  
Twenty-five of the original 31 participants completed the CBT treatment, with 24 
available for 6-month follow-up.  Results showed significant differences 
between the CBT and WLC groups on the primary outcome measures (CBS, 
YBOCS-SV, and CBS) with the significant improvements in the CBT group 
maintained at 6-month follow-up. The CBT treatment did not have a significant 
impact on any of the secondary outcome measures (i.e. SCL-90-R, BIS-11 and 
SI-R). Higher rates of pre-treatment hoarding traits were significant predictors of 
non-remission of symptoms, in addition to poor treatment attendance.  
 
14.5. Critique of group cognitive-behavioural therapy treatment studies 
Burgard et al., (2000; 2006) have developed a CBT group therapy manual for 
the treatment of compulsive buying which appears to have made a positive 
impact on CB symptoms, with effects maintained at follow-up. Both Burgard et 
al., (2000, 2006) and Mueller et al., (2008) utilised a number of valid 
assessment measures, including the CBS, YBOCS-SV and the SCL-90-R. 
Randomisation in the group studies allowed the CBT treatment to be 
systematically compared to a waiting list controls, increasing the validity of the 
claim that group CBT offers genuine potential for the treatment of CB. 
Limitations of both studies are that the sample was drawn via opportunistic 
sampling (i.e. media advertisements); and individuals who self-selected to take 
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part in the study may differ in important ways to other individuals with CB who 
may not present for treatment (e.g. motivation). The characteristics of the 
therapist delivering the group treatment programme (or needed to deliver the 
programme) were not described, and fidelity to the treatment model was not 
assessed. 
 
15. Summary of CBT treatment evidence 
In summary, empirical research regarding the efficacy and effectiveness of 
cognitive behavioural therapy (CBT) for the treatment of CB is gathering 
momentum. CBT has demonstrated effectiveness in the treatment of CB 
symptoms, across case studies (e.g. Kellett & Bolton, 2009), single-case 
experimental designs (Kellett & Robinson, 2009) and larger controlled trials 
(e.g. Mueller et al., 2008). Treatment fidelity (ensuring the intervention delivered 
adheres to the treatment model) is an important aspect of delivering manualised 
treatments (as within Burgard et al., and Mueller et al., 2008 studies), and future 
research should address this important methodological issue.   Criteria used to 
diagnose CB, in addition to outcome measures used are varied across studies, 
and the future standardisation of diagnostic criteria for CB would allow greater 
comparison between studies. A particular criticism of Burgard et al., (2006) and 
Mueller et al’s., (2008) sampling procedures is the reliance on opportunistic 
methods via media advertisements. Greater emphasis should be placed on 
gaining samples via clinical referral or comparing community and clinical 
populations, as there may be important differences in the manifestations of CB 
symptoms amongst these groups.  
 
  
44 
 
16. Family therapy treatment 
 
Park, Cho and Seo (2006) report findings of family therapy treatment13 of a 24-
year old female with CB. Fifteen family therapy sessions (comprising of a mix of 
individual, parental, family and telephone-based sessions) were conducted. 
Sessions were audiotaped/videotaped and analysed qualitatively, using 
grounded theory (Glaser & Strass, 1967; Strauss & Corbin, 1998).     
 
Results suggested six key factors related to CB; communication issues with 
family members; sibling relationships; mother‟s parenting and communication 
style; interpersonal relationships and stress. A number of factors which were 
reported to influence the change in the client‟s CB, including better 
communication with her family, developing closer sibling relationship, a change 
in her mother‟s parenting style, positive interpersonal relationships within the 
family and decreased family stressors.  
 
16.1. Critique of study 
This study provides a useful analysis of the treatment of CB within the family 
context (which is under-represented within the general literature in CB) but has 
several methodological limitations. Diagnostic criteria used to identify CB, or 
details of how the patient was selected for treatment are not reported. Details of 
                                            
13 Family therapy is a type of psychotherapy which considers the impact of wider familial relationships and 
dynamics upon individual psychological and emotional wellbeing (e.g. Dallos & Draper, 2000).  
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any relevant outcome measures of CB or related psychiatric problems that were 
employed are lacking. The family therapy approach used and/or any techniques 
utilised was not described, and fidelity to the family therapy models unassessed 
making this study difficult to replicate. No details regarding co-morbid diagnoses 
which may have been present in the individual treated were given.    In addition, 
this study was conducted within South Korea, which may limit the 
generalisability of the findings to other cultures.   
 
17. Summary of family therapy treatment evidence 
In summary, the evidence base for family therapy treatment is particularly small. 
Whilst the individual study of Park et al., (2006) reports that family therapy was 
beneficial in the treatment of CB, the study lacks methodological robustness 
from which to draw viable conclusions.  
 
18. LIMITATIONS OF RESEARCH 
 
18.1. Classification and conceptualisation of compulsive buying 
Consistent agreement regarding the classification and conceptualisation of CB 
remains elusive; whether CB is best understood as an impulse control disorder, 
part of the obsessive-compulsive spectrum or merely a social artefact, is still 
highly contested. The current divide regarding the classification of CB is 
problematic, in that treatments should be dependent on the development of an 
empirically based conceptual model. Over recent years, tentative models (e.g. 
Kellett & Bolton, 2009) have begun to emerge, which have synthesised the 
available empirical evidence into a conceptual framework which is hoped will 
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offer clinical utility in the understanding and treatment of this disorder. Kellett 
and Bolton (2009) proposed a cognitive-behavioural model of CB which 
organises the CB evidence around 4 key areas: (1) „antecedents’ including 
evidence suggesting persons with CB are more likely to have had difficult 
childhood experiences (e.g. neglect, abuse, critical parenting styles and low self 
esteem), or received parental care and attention via material gifts e.g. money or 
„treats‟; (2) ‘internal/external triggers’ including internal psychological processes 
(e.g. low mood, dissatisfaction with body image, tension and anxiety which 
typically seem to proceed compulsive shopping episodes, as well as external 
triggers (e.g. the design of retail environments themselves which actively 
encourage purchasing); (3) ‘The act of buying’ - cognitive and emotional 
changes resulting from the act of buying, (e.g. narrowed attention, poorer 
information processing and dissociative states) and (4) „post-purchase’ 
evidence that compulsive buyers typically experience a range of negative 
emotions and behaviours following shopping binges.  
 
18.2. Sampling issues 
Many of the treatment samples reported present with significant levels of co-
morbidity. Whilst some studies have included and treated patients with co-
morbid conditions as part of their compulsive buying (e.g. Black et al., 1997; 
Black et al., 1998; Koran et al., 2002, Koran et al., 2003; Koran et al., 2007; 
McElroy et al., 1991; McElroy et al., 1994; Mitchell et al., 2006; Mueller et al., 
2008; Ninan et al., 2000), others excluded patients with known co-morbidity 
(e.g. Black, 2000). Co-morbidity makes establishing which underlying clinical 
problem is actually being treated extremely difficult. Studies which attempt to 
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more stringently control for the presence of co-morbid conditions, or that 
compare outcomes of individuals with CB both with and without co-morbid 
conditions are required.   
More outcome research is needed with male compulsive buyers, as males are 
significantly under-reported in the treatment literature (Kellett & Bolton, 2009), 
whilst being equally represented in terms of general prevalence (e.g. Black, 
1996; Dittmar, 2004; Koran, Faber, Aboujaoude et al., 2006). Further general 
research examining possible gender differences in CB phenomena is also 
clearly needed. 
  
Almost half of all studies reported in the current review (43%) used opportunistic 
selection methods (e.g. media advertisement, word of mouth recruitment). 
Individuals who self-select to take part in treatment differ in important ways from 
those who do not in terms of clinical severity of problems and treatment 
motivation. More studies comparing community and clinical samples with CB 
are required.  
       
18.3. Measurement of compulsive buying  
Several studies employed the criteria outlined by McElroy et al., (1994) in the 
diagnosis of CB. However others have relied on standardised clinical measures 
(e.g. YBOCS-SV; Monahan et al., 1996) alone, or in conjunction with the 
McElroy (1994) criteria, or have relied purely on patient self-report of CB 
symptoms. Significant variability in the extent to which compulsive buying 
symptoms must be present for inclusion into research is evident. Some report 
CB symptoms must be present for 1-year or longer (e.g. Black et al., 1997; 
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Black et al., 2000; Koran et al., 2003, 2007), whereas others have no strict 
inclusion criteria (e.g. Grant 2003; Guzman et al., 2007; McElroy et al., 1991; 
McElroy et al., 1994).  For future research to progress, the standardisation in 
the assessment /diagnosis of CB is needed. 
 
18.4. Treatment fidelity 
There appears to be significant heterogeneity in treatment fidelity between 
studies. There has been some movement towards manualised treatments (e.g. 
Mueller et al., 2008), however the fidelity by which these treatments were 
delivered has not been addressed.  
 
18.5. Follow-up data 
Many of the studies reported (particularly pharmacological studies) have lacked 
follow-up data, which is problematic if any conclusive evidence regarding 
treatment effectiveness is to be established. Longitudinal data regarding 
treatment outcome is needed to help assess the impact of various treatments 
over time.  
 
19. Conclusion 
 
CB outcome studies have been presented and critically reviewed. Treatments of 
CB have historically focused primarily upon pharmacological methods; however 
contemporary studies show a move towards more psychotherapeutic 
approaches. Both pharmacological and therapeutic modalities of treatment have 
shown some success in the treatment of CB (see Table 3 for effect size 
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calculations amongst CB pharmacological and psychotherapeutic outcome 
studies). In terms of pharmacological treatments, antidepressants (e.g. McElroy 
et al., 1994), naltrexone (Grant, 2003), citalopram (Koran et al., 2003) and 
topiramate (Guzman et al., 2007) have shown positive results. However, only 
one study (Koran et al., 2003) has sufficient internal validity to draw valid 
conclusions from. At the present time, cognitive-behavioural therapy has also 
shown promise in the treatment of CB, which has also been supported via 
controlled evidence (Mueller et al., 2008). The progression of research from 
individual case reports to larger controlled trials is encouraging, in both 
pharmacological and psychotherapeutic studies. Future research comparing 
psychotherapeutic, pharmacological, and control groups would help to establish 
which treatment provides the greatest benefit.  
Empirical research assessing variability in CB symptoms across different 
populations is lacking. Most research has been limited to female, community-
based samples presenting with high levels of psychiatric co-morbidity.  More 
research is clearly needed to establish whether there are important differences 
in how CB symptoms may manifest amongst under-researched samples (e.g. 
males, clinical populations), as well as between CB sufferers with and without 
co-morbid psychiatric conditions.  Studies which directly compare clinical and 
community-based samples, males and females and individuals with and without 
psychiatric co-morbidity would aid our current understanding.  
  
Developing a shared, operationalised definition of CB is crucial in the effective 
diagnosis, measurement, understanding and treatment of this clinical disorder.   
Theoretical models of compulsive buying (e.g. Kellett & Bolton, 2009) are 
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beginning to emerge, and this represents a positive step towards the 
establishment of a standardised framework from which to develop future 
psychological treatments. Biological theories of CB are currently absent, despite 
the pharmacological outcome evidence. More studies capturing the „in vivo‟ 
cognitive, behavioural and emotional components of CB are now needed (e.g. 
see Kellett & Totterdell, 2008). Ecological momentary assessment techniques 
(see Smyth & Stone, 2003 for overview), including patient self-report and diaries 
recorded during shopping episodes, would enhance the outcome evidence-
base (Kellett & Bolton, 2009 p.95).  
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 An intensive time-series evaluation of the effectiveness of a cognitive-
behavioural treatment for compulsive hoarding: A two-year prospective 
study 
 
INTRODUCTION 
Compulsive hoarding in humans may have an evolutionary basis (Kellett, 2007; 
Leckman & Bloch, 2008), and is observed across a variety of other species 
(Kellett, 2007). The accumulation of items (e.g. food) is both functional and 
adaptive, ensuring survival and reproductive success during times of decreased 
availability (Grisham & Barlow, 2005; Leckman, Mataix-Cols & Rosario-
Campos, 2005). Putting together an ordered collection of desirable objects (e.g. 
records, toys, books) is for many a highly regarded and pleasurable pastime 
(Grisham & Barlow, 2005 p.45). For hoarders however, the reasons for saving 
or acquiring items appear irrational; objects seem to serve very little practical 
use and have no obvious theme (Frost & Hartl, 1996; Grisham & Barlow, 2005). 
Clutter and environmental chaos separates compulsive hoarding from everyday 
collecting and acquiring (Steketee & Frost, 2007), with the sheer volume of 
clutter creating often squalid and dangerous living conditions (Frost, Steketee & 
Williams, 2000).   
 
Severe hoarding interferes with the basic activities of daily life; including 
cooking, cleaning, eating and sleeping (Grisham, Frost, Steketee, Kim & Hood, 
2003; Steketee & Frost, 2003). Excessive clutter within the home environment 
is associated with significant health and safety risks, including poor hygiene and 
risk of fire (Frost, Steketee & Williams, 2000; Steketee, Frost & Kim, 2001). 
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Hoarding obviously has a negative impact upon family life, with carers and 
family members reporting frequent disruption to normal family life and conflict 
within their family relationships (Tolin, Frost, Steketee & Fitch, 2008; Wilbram, 
Kellett & Beail, 2008). Compulsive hoarding is a disorder often concealed by the 
sufferer (Kellett, 2007) and one which is frequently associated with significant 
personal shame and embarrassment, due to fear of negative evaluation 
regarding the state of the home (Kellett, Greenhalgh, Beail & Ridgway, 2010) 
 
Currently there is no formal psychiatric DSM-IV-R (American Psychiatric 
Association, 2000) diagnostic criterion for compulsive hoarding (Steketee & 
Frost, 2007).  Compulsive hoarding is typically identified via criteria developed 
by Frost and Hartl, (1996); 1) the acquisition of, and failure to discard a large 
number of possessions that appear to be useless or of limited value; 2) living 
spaces are sufficiently cluttered so as to preclude activities for which those 
spaces were designed; and 3) significant distress or impairment in functioning 
are caused by the hoarding. Compulsive acquisition of items and possessions is 
the primary feature of compulsive hoarding (Frost & Steketee, 1999; Pertusa, 
Frost, Fullana, Samuels, Steketee, Tolin, Saxena, Leckman & Mataix-Cols, 
2010). Reasons for saving are typically comparable to those given by non-
hoarders, including retaining items because of their perceived future usefulness, 
or sentimental value (Frost & Gross, 1993; Frost & Steketee, 1999; Furby, 
1978). Amongst hoarders however, emotional investment in items is heightened 
(Kim, Frost, Steketee, Tarkoff & Hood, 2003) so that discard becomes fraught 
with anxiety, with possessions functioning as extensions of core identity (Frost 
& Skeketee, 1999).  
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Hoarding and Obsessive Compulsive Disorder 
The Diagnostic Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 
(American Psychiatric Association, 1994) currently regards hoarding as a 
symptom of obsessive-compulsive personality disorder (OCPD), however, the 
exact nature of this relationship is highly contested (Pertusa et al., 2010; 
Steketee, Frost, Tolin & Brown, 2005). The excessive doubt, reassurance 
seeking and checking associated with discard in compulsive hoarding, is 
believed to be similar to the compulsive rituals observed within obsessive-
compulsive disorder. Furthermore, OCD symptoms have been found to 
correlate highly with compulsive hoarding behaviours in some individuals (e.g. 
Frost & Gross, 1993; Frost, Steketee, Williams et al., 2000). However, many 
studies has failed to differentiate between hoarders with and without co-morbid 
OCD (Pertusa et al., 2010), and therefore it is possible that such findings could 
in part be explained by co-morbid OCD symptomology amongst hoarders 
(Pertusa et al., 2010), rather than reflecting a genuine association between 
OCD and compulsive hoarding. There have been recent calls to define OCD 
and compulsive hoarding as separate clinical entities (Pertusa, Fullana, Singh, 
Alonso, Mechon & Mataix-Cols, 2008; Pertusa et al., 2010) and to distance 
compulsive hoarding from OCD in future diagnostic classification criteria 
(Mataix-Cols, Frost, Pertusa, Clark, Saxena, Leckman, Stein, Matsunaga & 
Wilhelm, 2010). The experience of both OCD sufferers and compulsive 
hoarders appears to be qualitatively different; compulsive hoarders do not 
typically experience their behaviour as an attempt to reduce distress or anxiety 
(as is often reported amongst OCD sufferers) and may instead see the 
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accumulation of objects as both comforting and pleasurable (Kyrios, Steketee, 
Frost & Oh, 2002; Kellett, 2007; Kyrios, Steketee, Pertusa et al., 2010).  
 
Treatment of compulsive hoarding 
Extant knowledge regarding the impact and long-term effectiveness of 
treatments for compulsive hoarding is limited (Steketee & Frost, 2003; Tolin, 
Frost & Steketee, 2007).   
Efficacious treatments for OCD, including pharmacological, psychological (e.g. 
CBT based exposure and response prevention - ERP) and combined 
treatments (see NICE, 2005 for overview), have shown disappointing results in 
the treatment of compulsive hoarding (Steketee & Frost, 2003). In a sample of 
150 patients with OCD treated with SRI‟s, the presence of hoarding symptoms 
predicted negative response (Mataix-Cols, Baer, Rauch & Jenike, 2000). 
Similarly, in a combined treatment study, Black, Monahan, Gabel, Blum, Clancy 
and Baker, (1998) reported that in 38 individuals with OCD treated with 
paroxetine and CBT, outcomes were significantly poorer amongst those with 
hoarding symptoms than without (16% versus 67%, respectively).  Abramowitz, 
Franklin, Schwartz and Furr (2003) reported significantly poorer response rates 
for OCD hoarders with ERP treatment compared to those for individuals without 
hoarding symptoms.  Individuals with co-morbid hoarding symptoms are more 
likely to drop out of treatment, compared to those without (Ball, Baer & Otto, 
1996; Mataix-Cols, Marks, Greist, Kobak & Baer, 2002).  Compulsive hoarding 
is ego-syntonic; hoarders see their thoughts, feelings and behaviour as rational; 
and analogous to beliefs they hold about themselves and their identity (Frost & 
Skeketee, 1999; Steketee & Frost, 2003). Compared to individuals with OCD, 
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who recognise the irrationality in thoughts and compulsions, there is often a 
resistance to seek or engage with treatment amongst hoarders (Frost & Gross, 
1993) due to lack of insight and/or denial of the severity of their difficulties (e.g. 
Pertusa et al., 2010; Steketee & Frost, 2003; Tolin, Fitch, Frost & Steketee, 
2010). The internal motivation or will to engage with or complete treatment 
programmes is often absent (Skeketee & Frost, 2003; Tolin, Frost & Steketee, 
2007). Often, it is only via the pressure exerted by family members or 
professionals (e.g. local housing authorities), that hoarders present in mental 
health services (Christensen & Greist, 2001; Greenberg, 1987).  
 
In recent years, there has been a move towards the treatment of compulsive 
hoarding as a unique clinical disorder (Steketee & Frost, 2003). Primarily, the 
majority of research concerning the treatment of compulsive hoarding as a 
distinct from OCD, has focused on the application of the cognitive behavioural 
therapy (CBT) model of compulsive hoarding developed by Frost and Hartl, 
(1996). The model proposes compulsive hoarding is associated with deficits in 
four main areas, namely; (1).Vulnerability Factors Information processing (e.g. 
problems with the organisation and categorisation of objects and decision 
making) in addition to core beliefs about self, core personality traits and 
underlying/co-morbid mood disorders or past trauma; (2). Beliefs/Attachment 
Beliefs about attachment to objects (e.g. overinflated emotional attachment to 
possessions) in addition to beliefs about vulnerability, personal responsibility, 
memory and control; (3). Emotional Reactions Both positive and negative 
emotions resulting from hoarding including pleasure, pride, sadness, grief and 
shame; and (4). Hoarding Behaviours Reinforced by positive or negative 
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emotions when thinking about or attempting to discard particular objects; 
leading to avoidance behaviours. 
 
Specialised CBT treatment for compulsive hoarding has evidenced 
effectiveness in the small number of psychological studies published (Cermele, 
Melendez-Pallitto & Pandina, 2001; Frost, Steketee & Greene, 2003; Hartl & 
Frost, 1999; Kellett, 2006; Murnoff, Steketee, Rasmussen, Gibson, Bratiosis & 
Sorrentino, 2009; Steketee, Frost, Winze, Greene & Douglass, 2000; Tolin, 
Frost & Steketee, 2007; Turner, Steketee & Nauth, 2010). Improvements have 
been noted across a range of hoarding related outcome measures, including 
visual ratings of clutter (e.g. Cermele et al., 2001; Hartl & Frost, 1999; Murnoff 
et al., 2009; Steketee et al., 2000; Tolin et al., 2007; Turner et al., 2010), the 
Yale-Brown Obsessive Compulsive Scale (Frost & Steketee, 1999; Frost, et al., 
2003; Steketee et al., 2000) and Saving Inventory-Revised (Muroff et al., 2009; 
Tolin et al., 2007).  Reliance on small samples, inclusion of individuals with co-
morbid diagnoses (e.g. Steketee et al., 2000), poor standardisation of treatment 
protocols and limited or non-existent follow-up data are common methodological 
weaknesses. CBT treatment for individuals who hoard is primarily based on 
improving decision making skills, ability to sort and categorise objects, 
enhancing motivation, and restructuring maladaptive thoughts and feelings (e.g. 
sentimental attachment) associated with possessions. Home visits as an aspect 
of treatment has been hypothesised to aid progress and encourage discard 
(Nesiroglu, Bubrick & Yaryura-Tobias, 2004; Steketee & Frost, 2007), although 
this has not been formally evidenced.  
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Typically, outcome studies published thus far have been small n designs, 
including case reports (e.g. Cermele et al., 2001; Frost & Hunt, 2000; Frost, 
Steketee & Green, 2003; Kellett & Knight, 2003); single case experimental 
designs (SCED) (e.g. Hartl & Frost, 1999; Kellett, 2006) or small group and 
individual CBT programmes (Frost et al., 1999; Steketee et al., 2000; Tolin, et 
al., 2007) including more recently, the individual treatment of 6 older adults with 
hoarding difficulties in a community setting (Turner, et al., 2010). A preliminary 
trial of a larger CBT group programme, based on Tolin et al.‟s (2007) pilot study 
with (n=32) clients (Murnoff, et al., 2009) reported significant pre to post 
improvements on a number of hoarding outcomes. However, a high proportion 
of participants within the study presented with OCD symptoms, in addition to 
compulsive hoarding, (problematic for reasons discussed previously – see 
Pertusa et al., 2010) and no follow-up data were collected, meaning the long-
term benefit of this group programme could not be assessed.  
 
Studies investigating the inter-relationship between cognitive, affective and 
behavioural factors during treatment, and their influence upon key 
environmental outcomes are currently lacking (Steketee & Frost, 2003 p.915). 
To address this issue, the current study utilised an intensive time-sampling 
method conducted over a 24-month period. The study measured diary ratings of 
cognitions, mood and hoarding via a single-case experimental design (SCED), 
with extended follow-up. SCED usefully assesses clinical change in disorders 
with a limited evidence base (Bower & Gilbody, 2010; Turpin, 2001). 
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The research hypotheses for the study were therefore: 
    
H1: There will be reliable improvements in psychometric outcomes and 
environmental clutter between baseline, end of treatment and follow-up.  
H2: There will be a significant increase in total volume of discard during 
outpatient therapy, outpatient therapy augmented by domiciliary visits 
and follow-up, compared to baseline. 
H3: There will be a significant increase in incidence of discard during 
outpatient therapy, outpatient therapy augmented by domiciliary visits 
and follow-up, compared to baseline. 
H4: There will be a significant increase in incidence rate of discard during 
outpatient therapy augmented by domiciliary visits over and above solely 
outpatient therapy, due to the addition of domiciliary visits.  
H5: There will be reductions in hoarding related cognitions, behaviour and 
affect during outpatient therapy, outpatient therapy augmented by 
domiciliary visits and follow-up, compared to baseline.  
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METHOD 
 
    Participant 
The patient was a 63-year old married woman, referred to a community mental 
health team due to a history of obsessive compulsive disorder (OCD) of the 
contamination type, compulsive hoarding and depressive symptoms. Primarily, 
the main presenting difficulty was compulsive hoarding and the patient was 
seeking help for this as a priority. The patient had a previous psychiatric history 
spanning 20-years and had sought treatment from both primary care and 
secondary care mental health services several times during this period. The 
patient reported difficulties with hoarding behaviour since her early life. Her 
hoarding behaviour had caused significant difficulties in her relationship with her 
husband and family and the patient reported feeling too ashamed of her home 
to allow her family and friends to visit. The patient had previously received 24 
sessions of CBT for her OCD by a community nurse, which had failed to 
recognise or address compulsive hoarding symptoms and the patient dropped 
out of treatment. The patient lived in a 3-bedroom house with her husband.  The 
patient‟s husband reported feeling afraid of upsetting his wife by intervening 
with removing clutter from the home. He reported he had passively accepted 
their home environment despite feeling frustrated by the negative impact it had 
on their marital relationship, relationships with other family members and the 
living environment they shared together. The home was observed to be 
moderately cluttered, although two rooms could not be entered due to the 
extent of clutter within them. Throughout the duration of the study, the patient 
was taking an SSRI anti-depressant, Citalopram 60mg/d.   
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 Procedure  
 
Intervention 
The current study utilised an A, B, C plus extended follow-up (D) single case 
time-series design spread over 644 days (92 weeks). Table 1 describes the 
phases, duration and location of the study. The CBT assessment and treatment 
of the patient was completed by a British Association for Behavioural and 
Cognitive Psychotherapies (BABCP) accredited Consultant Clinical 
Psychologist.  The intervention was based on a collaboratively developed 
individual case formulation, which drew upon the four-factor cognitive-
behavioural model of compulsive hoarding outlined by Frost and Hartl, (1996). 
The formulation helped to direct the therapeutic sessions and enabled the 
patient to reflect on their hoarding difficulties. The purpose of the formulation 
was to enable the patient to understand the relationship between historical 
factors (e.g. early experiences), thoughts, feelings, avoidance and safety 
behaviours. The patient reported feeling incompetent in her abilities and had 
core beliefs of worthlessness and helplessness. The patient reported feeling 
submissive to those around her and believed she had little control in her life. 
The patient described feeling criticised by others and was generally mistrustful 
of others. The patient reported that she had hoarded possessions since her 
early life but this had accelerated during a previous marital breakdown. She 
reported saving objects due to their perceived future usefulness, often reporting 
something would „come in handy‟ at a later date. The patient also frequently 
retained items for sentimental reasons; particularly children‟s toys and books 
because of the pleasant memories they triggered for her. The patient described 
  
74 
significant anxieties around her memory, fearing that if she did not keep objects 
close by she would forget about them or lose them. During the intervention the 
client displayed significant difficulties in being able to sort and prioritise objects 
for discard, and one component of the intervention involved helping the client 
speed up decision making around objects selected.  
 
Table 1. SCED phases, durations and sessions           
        
Sessions 1 and 2 were completed as part of baseline assessment (A); sessions 
3 to 25 comprised outpatient sessions (B); sessions 26-47 outpatient 
augmented by domiciliary visits (C); and sessions 48-51 patient follow-up (D). 
Therapy took place approximately once-fortnightly during the outpatient therapy 
(B) and twice weekly during therapy augmented by domiciliary visits (C). Both 
outpatient and domiciliary therapy sessions lasted 50-minutes in total. At the 
start of the assessment, a daily diary of mood, thoughts, feelings and behaviour 
related to hoarding was mutually designed and psychometric measures 
completed. Outpatient therapy (OPT) implemented the Steketee and Frost 
(2007) treatment manual for hoarding, in combination with an Object-Affect 
Fusion (OAF) protocol (Kellett & Knight, 2003). 
 
SCED Phase 1 (A) Phase 2 (B) Phase 3 (C) Phase 4 (D) 
Activity Baseline Outpatient 
Therapy (OPT) 
Outpatient 
treatment + 
domiciliary visits 
(OPT+DV) 
Follow-up 
period 
Sessions Sessions 1-
2 
Sessions 3-25 Sessions 26-47 Sessions 48-51 
Duration 4 weeks 35 weeks 30 weeks 23 weeks 
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The Steketee and Frost (2007) manual details procedures for 1. Psycho-
education around compulsive hoarding behaviour; 2. Training in speeding up 
decision making and categorisation of objects; 3. Exposure and habituation to 
discarding objects; and 4. Cognitive restructuring. The Object-Affect Fusion 
(OAF) (Kellett and Knight, 2003) procedure facilitated cognitive restructuring 
regarding hoarding possessions. The five stage procedure, outlined in Kellett, 
(2006) involved 1. Identification: Identification of objects selected for discard; 2. 
OAF description: Patient names the object and describes feelings, emotions 
and memories associated and fused with that object; 3. Cognitive challenge: 
Psychoeducation and cognitive challenge relating to emotional fusion 
associated with objects selected. The patient is introduced to the notion of 
separating objects from feelings, emotions memories and associations that the 
objects trigger; 4. Affective expression Therapeutic component whereby patient 
is encouraged to reflect and process unexpressed emotional affect (e.g. grief). 
Therapist supports patient in recognising and separating historical events and 
their own personal identity from material objects; and 5. Developing a plan for 
discard traditional CBT approach outlined by Steketee & Frost (2007) involving 
speeding up decision making regarding objects selected for discard, exposure 
to the act of discard and exposure to emotional consequences of discard. 
 
 Assessment measures 
 
 Self-report 
Six measures were collected via a daily diary throughout the study, as 
described in Table 2. Daily diary recording offers a useful approach to 
examining within-person variability in mood and behaviour over time, in a way 
  
76 
which is not always achievable using other methods, such as formal 
psychometrics (Reis & Judd, 2000). Variables were mutually designed based 
upon integration of empirical research of factors salient in compulsive hoarding 
and patient choice, namely; rumination (e.g. Frost & Hartl, 1996; Steketee & 
Frost, 1998) hyper object sentimentality (e.g. Kellett & Knight, 2003; Kellett, 
2006), depression (e.g. Grisham, Steketee & Frost, 2007), anxiety (e.g. Frost, 
Steketee, Williams & Warren, 2000), shame (e.g. Kellett et al., 2010) and 
avoidance behaviour (e.g. Frost & Hartl, 1996).    
 
Table 2. Diary hoarding variables 
Construct Diary item Frequency Scale 
Past „I‟ve been living in the past 
today‟ 
 
Daily 0 „not at all‟ to 9 „totally‟ 
Sentimentality „I‟ve been sentimentally 
attached to my 
possessions today‟ 
 
Daily 0 „not at all‟ to 9 „totally‟ 
Depression Today I have felt: 
‟depressed‟ 
 
Daily 0 „not at all‟ to 9 „totally‟ 
Anxiety Today I have felt: ‟anxious‟ 
 
Daily 0 „not at all‟ to 9 „totally‟ 
Shame Today I have felt: 
„ashamed‟ 
 
Daily 0 „not at all‟ to 9 „totally‟ 
Avoidance „I have avoided throwing 
things way today‟  
 
Daily 0 „not at all‟ to 9 „totally‟ 
Actual discard „Please list below what you 
have thrown away today:‟ 
Daily Patient provided list of items 
discarded 
 
 
Psychometric Measures 
The patient completed five self-report psychometric outcome measures at 
assessment, end of OPT, end of OP+DV and end of follow-up (see Appendix 
F):  
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Beck Depression Inventory (BDI-II; Beck, Steer & Brown, 1995) 
The BDI-II is a 21-item measure designed to assess depressive symptomology 
(Beck et al., 1995). Respondents rate depressive symptoms, ranging from 0 
(not present) to 3 (severe), during the past two weeks. The BDI-II provides a 
single overall score from 0 to 63. Cut-off scores are suggested as: minimal (0–
13); mild (14–19); moderate (20–28); and severe (29–63). Beck, Steer, Ball and 
Ranieri, (1996) report high internal consistency (α = .91 among psychiatric 
outpatients and α = .93 among undergraduate students) and good convergent 
validity with other measures (e.g., r = .93 with the BDI-IA and r = .71 with the 
Hamilton Psychiatric Rating Scale for Depression). 
 
Brief Symptom Inventory (BSI; Derogatis, 1987) 
The BSI is a 53-item measure covering nine symptom dimensions: 
Somatization, Obsession-Compulsion, Interpersonal Sensitivity, Depression, 
Anxiety, Hostility, Phobic Anxiety, Paranoid Ideation and Psychoticism. Three 
global indices of distress can be calculated: 1) Global Severity Index, 2) Positive 
Symptom Distress Index, and 3) Positive Symptom Total. The global indices 
measure current or past level of symptomatology, intensity of symptoms, and 
number of reported symptoms. Questions are on a 5-point scale, from 0 = "not 
at all", to 4 = "extremely". Internal consistency for the BSI is high, with alphas 
ranging from α .71 to α .85, test retest reliability ranging from .68 to .91, and 
good convergent, discriminant, and construct validity (Derogatis, 1993). 
Derogatis (1992) suggests a t-score of >63 as a cut-off indicating significant 
distress and clinical caseness based on community norms.  
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Inventory of Interpersonal Problems (IIP-32; Barkham, Hardy & Startup, 1996) 
The IIP-32 is a 32-item measure containing eight scales. Four measure deficits 
in interpersonal functioning (e.g. hard to be assertive), and four dysfunctional 
interpersonal strategies (e.g. too dependent). The eight subscales have 
demonstrated good internal consistency with alphas ranging from α .72 to α .90 
(Barkham et al., 1996) and test-retest reliability of .70 in a general population 
sample (Barkham, et al., 1996). A score of >1.44 is the recommended cut-off for 
outpatient clinical caseness (Barkham et al., 1996). For a full review of the 
psychometric properties of this item, see Hughes & Barkham, (2005). 
 
Compulsive Acquisition Scale (CAS; Frost, Kim, Morris, Bloss, Murray-Close & 
Steketee, 1998) 
The CAS is an 18-item scale that measures the strength of acquisition 
compulsions (CAS; Frost et al., 1998). Two subscales can be calculated for the 
CAS; the CAS-Buy subscale (12 items) is a measure of compulsive buying 
behaviour and its consequences, the CAS-Free subscale (6 items) measures 
the compulsive acquisition of free things. Each subscale has been found to 
demonstrate adequate reliability (α .90 and α.83, respectively). Frost and Gross, 
(1993) and Frost et al., (1995) report the CAS is a reliable and valid measure of 
hoarding behaviour across student, clinical and community samples (Frost et 
al., 1998 p.659). A cut-off score of > 47.8 is recommended to differentiate 
clinically significant compulsive buyers from non-compulsive buyers (Frost, 
Steketee & Williams, 2002).  
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Saving Inventory Revised (SI-R, Frost, Steketee & Grisham, 2004) 
The SI-R is a 23-item measure of compulsive hoarding behaviours relating to 
three main factors: 1. difficulty discarding, 2. excessive clutter and 3. excessive 
acquisition. The SI-R has been found to be a valid measure of hoarding 
behaviours in both clinical and non-clinical populations (Coles, Frost, Heimberg, 
& Steketee, 2003; Frost et al., 2004) with good test-retest reliability and strong 
internal consistency (α= .92). Alpha coefficients for the three subscales exceed 
α .87. A cut-off of > 40 on the Total SI-R score is recommended to differentiate 
clinically significant compulsive hoarders from non-compulsive hoarders 
(Mueller et al., 2007 p.2756).   
 
Clutter levels within the home  
Video data of footage of the home environment was gathered at baseline, end 
of OPT and end of OP+DV. A total of 6 videos were filmed (approximately 10 
minutes in length) containing footage of the upstairs and downstairs areas of 
the home. Three independent raters were shown the 6 excerpts by the current 
researcher. Excerpts were randomised, and raters were blind to the stage of 
treatment shown in the videos. Excerpts were analysed and given an overall 
rating of „clutter‟ by the 3 raters using the Clutter Image Rating (CI-R) tool 
(Frost, Steketee, Tolin & Renaud, 2008). Instructions for raters are in Appendix 
H. The CI-R has good internal consistency (α = 0.84 Frost et al., 2008). For the 
current study purposes, the CI-R was used as a visual guide for raters as an 
assessment of clutter within the home as indicated on video footage.  Inter-rater 
reliability was examined using intraclass correlation (ICC). Results show 
intraclass correlation between raters was high (ICC = .88).  The total score of 
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clutter amongst the three raters was then averaged to provide a mean rating of 
clutter for the six videos: baseline (upstairs/downstairs); OPT: 
(upstairs/downstairs) and OPT+DV (upstairs/downstairs).  
   
Discard data 
The patient recorded daily discard in the diary measure which was analysed 
using a system designed for the current study. Objects discarded each day 
were firstly assigned to one of three major categories: (1) information based 
objects (e.g. newspapers, leaflets etc.); (2) household waste objects (e.g. food, 
packaging etc.) and (3) clothing and footwear objects (e.g. shoes, trousers etc.). 
A frequency count of objects listed was then calculated, in addition to a total 
frequency count for each major category. Finally, the total volume of objects 
discarded daily overall (each category combined) was calculated using a 
Volume of Discard Scale (VDS) designed for this study (see fig. 1 for Volume of 
Discard Scale). The VDS is a visual 1-4 analogue scale designed to assess 
how much of a household refuse bag the items discarded would fill. 
 
 An inter-rater reliability analysis of the VDS ratings was undertaken with three 
raters (including the researcher) using a sample of 10-days of patient self-
reported daily discard. Diary samples were selected if they contained a range of 
items listed, had variations in total volume and contained some items likely to 
be ambiguous in how they were categorised or counted. Each rater was 
provided with instructions for categorising and calculating frequency (see 
Appendix G), and provided with a VDS scale for each sample day.  The task of 
each rater was as follows: 1) examine each daily discard recording 2) place 
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each item discarded within one of the three major categories; 3) calculate the 
frequency of that object; 4) calculate the total frequency of each major category; 
and 4) calculate the total volume of daily discard.  
Internal reliability of discard categories was high for each category (information 
α = .99; household α = .86; clothing α = 1.0). VDS results demonstrated high 
internal consistency between raters (α = .91), indicating the VDS as a reliable 
measure of daily volume of discard.  
 
Fig 1. Volume of Discard Scale 
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RESULTS 
All variables were screened for normality prior to statistical analysis. Data 
relating to categories of discard (i.e. information, household, or clothing objects) 
contained a number of outliers, which were removed. Outliers were pre-defined 
as any number greater that two standard deviations above the mean frequency 
totals. A visual inspection of frequency histograms for diary measures was then 
undertaken (see Appendix E). All daily diary variables were either positively or 
negatively skewed. Frequency of types of objects discarded each day and the 
total volume discarded was also skewed. This was caused by high levels of 
variability within daily discard frequency totals. A square root transform on the 
data failed to solve the problem. Dichotomising these variables would have led 
to information regarding the patient‟s pattern of discard being lost, and therefore 
a decision was made to proceed with the statistical analysis of these variables 
on the basis that the chosen parametric test (ANOVA) is robust to deviations 
from normality (Lindman, 1974).  
Time-series data contains long-term trends and cycles both within and between 
variables which can lead to a misinterpretation of treatment effect, if not 
adequately accounted for (Reis & Judd, 2000 p.65). The issue of serial 
dependency concerns the phenomenon whereby individual observations (in the 
current case, daily diary ratings) may be influenced by previous recordings, or 
show similar patterns at certain intervals over time (Reis & Judd, 2000). If the 
time frame between measurement periods is small, the risk of previous data 
points influencing subsequent data points can be high and spurious correlations 
between study variables may emerge (Beal & Weiss, 2003). Creating a „lagged‟ 
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variable, whereby each previous observation point in the time-series data is 
treated as an explanatory factor in the outcome of the analysis, can help to 
ensure each observation is treated as independent and control the risk of data 
becoming auto-correlated (Chatfield, 2000). Lagged variables for each data 
point in the current data set (specified as T-1 in SPSS syntax) were therefore 
created in SPSS to remove serial dependency.   
 
Table 3 reports the means and standard deviations of the diary variables at 
baseline, OPT, OP+DV and follow-up.  
 
A Pearson‟s correlation analysis of all diary measures during each phase was 
conducted (see Table 4).  The most salient findings of the correlation analysis 
are reported below: 
 
During baseline, living in the past was highly correlated with sentimentality (r 
(28) = .600, p < .01); sentimentality was highly correlated with anxiety (r (28) = 
.685, p <.01); and shame was highly correlated with depression (r (28) =. 482, p 
<.01). As treatment commenced during OPT, avoidance became highly 
correlated with anxiety (r (204) =. 333, p < .01), depression (r (204) = .348, p 
<.01) and shame (204) =.424, p <.01); associations which were maintained 
during OPT+DV but no longer significant at follow-up.  During OPT, living in the 
past became highly correlated with ratings of avoidance (r (210) = .426, p <.01), 
anxiety (r (208) =.452, p <.01), depression (r (208) = .414, p <.01) and shame (r 
(208) =.416, p <.01) compared to baseline; associations which were maintained 
during OPT+DV. During the follow-up phase, living in the past was no longer 
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associated with sentimentality (r (140) = .139, p >.05), and sentimentality no 
longer associated with anxiety (r (135) =.054, p >.05). Depression remained 
highly correlated with shame (r (198) =.506, p <.01), an association which was 
observed throughout the treatment phases OPT (r (210) =.470, p <.01); 
OPT+DV (r (197) =.506, p <.01). 
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Table 3. Descriptive statistics for patient variables during study phases 
 
 
Baseline Outpatient therapy 
     Outpatient therapy 
augmented by 
domiciliary visits  Follow-up 
Variables N Mean s.d N Mean s.d N Mean s.d N Mean s.d 
 
Living in the past 28 7.57 
 
0.8
3 
212 7.08 
 
0.8
0 
192 6.27 
 
0.7
0 
141 5.91 0.84 
 
Sentimentality 28 7.71 
 
0.8
5 
211 6.91 
 
0.7
3 
192 5.89 
 
0.6
5 
140 5.40 0.56 
 
Avoidance 22 7.59 
 
1.0
9 
210 6.54 
 
0.6
7 
191 5.70 
 
0.6
8 
140 5.38 0.64 
 
Anxiety 28 7.89 
 
0.8
3 
212 7.48 
 
0.7
3 
200 7.29 
 
0.6
9 
137 6.70 0.70 
 
Depression 28 7.71 
 
0.7
6 
212 7.40 
 
0.8
3 
200 7.29 
 
0.7
8 
137 6.72 0.65 
 
Shame 28 7.53 
 
1.0
3 
212 6.93 
 
0.7
0 
199 6.89 
 
0.7
2 
137 7.05 0.61 
 
Discard-information 28 .07 
 
0.3
7 
243 2.07 
 
6.1
6 
210 3.64 
 
8.1
4 
160 1.03 3.9 
 
Discard-household 28 .14 
 
0.4
4 
243 1.97 
 
4.1
1 
210 4.16 
 
6.9
2 
160 4.10 6.9 
 
Discard-clothing 28 .03 
 
0.1
8 
243 2.55 
 
4.4
1 
210 1.81 
 
3.8
3 
160 1.15 3.3 
 
Discard volume 28 .28 
 
0.8
0 
243 1.91 
 
1.5
9 
210 2.06 
 
1.6
2 
160 1.73 2.0 
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Table 4. Correlation matrix of daily diary variables over study phases  
(A) Baseline 
 
Variable 1 2 3 4 5 6 
1. Past        
2. Sentimentality .600**      
3. Avoidance .448 .277     
4. Anxiety .030 .685** .199    
5. Depression .172 .325 .448* .242   
6. Shame .099 .430* .527* .456* .482**  
** <0.01, * <0.05 
 
(B) Outpatient therapy 
 
Variable 1 2 3 4 5 6 
1. Past        
2. Sentimentality .521**      
3. Avoidance .426** .212     
4. Anxiety .452** .262** .333**    
5. Depression .414** .392** .348** .215   
6. Shame .416** .368** .424** .537** .494**  
** <0.01, * <0.05 
 
 
(C) Outpatient augmented by domiciliary visits 
 
Variable 1 2 3 4 5 6 
1. Past        
2. Sentimentality .479**      
3. Avoidance .445** .554**     
4. Anxiety .340** .310** .289**    
5. Depression .234** .275** .299** .459**   
6. Shame .158* .169* .225** .386** .506**  
** <0.01, * <0.05 
 
 
(D) Follow-up 
 
Variable 1 2 3 4 5 6 
1. Past        
2. Sentimentality .139      
3. Avoidance -.026  .489**     
4. Anxiety .371**  .054  .066    
5. Depression .211*  .139 -.022 .476**   
6. Shame .116 -.038 -.011 .343** .565**  
** <0.01, * <0.05
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Hypothesis 1 
To test the hypothesis that there would be a reliable change on outcome 
measures (i.e. BDI, BSI, IIP-32, CAS, SI-R) over time, the measures were 
analysed using the Jacobson and Traux (1991) formula. Table 5 describes 
outcome scores during baseline, OPT, OPT+DV and follow-up. Reliable change 
indices (RCIs) were significant between baseline and end of OPT for the BDI-II 
(RCI = 2.60, p <.05), BSI-GSI (RCI = 2.69, p <.05) and SI-R (RCI = 6.55, p 
<.05) scores, but not for the IIP-32 or CAS scores. During OPT+DV, RCIs were 
significant for BDI-II (RCI = 2.31, p < .05), CAS (RCI = 4.45, p < .05) and SI-R 
(RCI = 3.07 p < .05), but not for the BSI-GSI or IIP-32 measures, compared to 
baseline. At follow-up, all measures with the exception of the IIP-32 showed 
reliable improvement compared to baseline; BDI-II (RCI = 8.38, p < .05), BSI-
GSI (RCI = 2.51, p < .05), CAS (RCI = 5.94, p <.05) and SI-R (RCI = 11.34, p 
<.05).  
An additional part of the analysis was to examine whether there were reliable 
changes in the visual levels of clutter within the upstairs and downstairs areas 
of the patient‟s home, as measured via the CI-R (Frost, et al., 2008). Video data 
for the follow-up period was not collected, and therefore a comparison between 
OPT and baseline, and OPT+DV and baseline was conducted. During OPT, the 
RCI was significant for the upstairs area of the patient‟s home (RCI = 2.93, p < 
.05), but not for the downstairs area of the home (RCI = 0.18, p > .05), 
compared to baseline. This finding was replicated during OPT+DV; the upstairs 
area, but not the downstairs area, showed reliable change compared to 
baseline (upstairs RCI = 4.39, p <.05; downstairs RCI = 0.35, p >.05). 
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Therefore, the results of the first hypothesis can be partially supported; at the 
end of treatment, the patient showed significant improvements in levels of 
depression, general mental health, compulsive acquisition and saving, but not 
interpersonal functioning. Furthermore, changes in clutter were only significant 
for the upstairs area of the home.  
 
Table 5. Scores on outcome measures during study phases 
 Baseline Therapy Therapy plus 
domiciliary 
visits 
Follow-up 
BDI-II 41 32* 24* 12* 
BSI-GSI 2.15 2.01* 2.20 1.37* 
IIP-32 1.43 1.62 1.68 1.09 
CAS 65 56 29* 29* 
SI-R 86 42* 23* 16* 
CI-R upstairs 7.33 4.66* 3.33* - 
CI-R 
downstairs 
4.66 5.11 4.33 - 
**<0.01, *<0.05 
Hypothesis 2 
To test the hypothesis that there would be an increase in volume of discard 
during OPT, OPT+DV and follow-up compared to baseline, ANOVA was 
conducted, with volume of discard entered as the dependent variable, stage of 
treatment entered as the fixed factor and lag of volume entered as the 
covariate. Simple contrasts comparing therapy and follow-up with baseline were 
computed. Stage of treatment was significant for volume of discard F(1,635) = 
4.5, p <.01 during all stages, with the patient showing an increase in daily 
  
89 
volume of discard compared to baseline during OPT (F(1,635) = 3.33, p <.01); 
OPT+DV (F(1,635) =3.60, p <.01) and follow-up (F(1,635) =2.89, p <.01). In 
order to examine whether this finding could be accounted for via changes in the 
diary variables, the analysis was repeated with all diary variables (past, 
sentimental, avoidance, anxious, depressed, and ashamed) were entered as 
additional covariates. Stage of treatment remained significant for volume of 
discard during all stages; OPT F(1,28) = 3.52, p < .01; OPT+DV F(1,243) = 
3.29, p < .01; and follow-up F(1,160) = 2.44, p < .05. However, several daily 
diary variables also remained significant; living in the past F(1,573) = 5.48, p < 
.05; sentimentality F(1,571) = 10.68, p < .01;  avoidance F(1,563), p < .05; and 
shame F(1,576) = 8.07, p < .01.  Therefore results suggest that whilst total 
volume of discard increased as a result of therapy, this increase is likely to be 
partially accounted for by variables living in the past, sentimentality, avoidance 
and shame.  
 
An additional aspect of discard analysis examined whether the overall 
frequency of objects discarded increased as a result of therapy. An ANCOVA 
was conducted, with the overall total of objects discarded each day entered as 
the dependent variable, stage of treatment entered as the fixed factor and the 
daily lag of overall discard entered as the covariate. Simple contrasts with 
baseline as the reference category were computed. Stage of treatment was 
significant for total daily frequency of discard F(3,636) = 11.76, p <.01 during all 
study stages: OPT F(1,636) = 4.59, p <.01; OPT+DV F(1,636) = 0.47, p <.01; 
and follow-up F(1,636) = 2.77, p <.01; compared to baseline.  Figure 2 provides 
visual evidence of the overall mean frequency of objects discarded during each 
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week of the study. The data indicate overall mean frequency of discard is 
increased over all stages, compared to baseline. However the data also 
appears to show a downward trend towards decreased discard during follow-up. 
 
Fig 2. Mean total frequency of discard over study phases 
 
 
 
 
Type of objects discarded (i.e. information, household or clothing objects) 
during treatment phases was then compared to baseline. Cases of actual 
recorded discard were selected, and an analysis of covariance (ANCOVA) 
conducted. Type of discard was entered as the dependent variable, stage of 
treatment entered as the fixed factor and lag of the dependent variables entered 
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as covariates. Simple contrasts with baseline as the reference category were 
computed.   
 
There was no significant difference between type of objects discarded 
(information/household/clothing) compared to baseline during OPT or OPT+DV. 
During follow-up, the patient showed a significant increase in ability to discard 
household waste objects compared to baseline (F(1,633) = 2.56, p <.05), but 
information and clothing objects were non-significant.     
 
Results of the analyses indicate that volume of discard increased as a result of 
treatment, supporting the second hypothesis. Additional analysis indicate 
increase in volume is partially explained by changes on daily diary variables 
living in the past, sentimentality, avoidance and shame. Daily frequency of 
discard increased as a result of therapy, but shows a downwards trend towards 
decreased discard during follow-up. The patient showed a significant increase 
in ability to discard household waste objects during follow-up, compared to 
baseline but no difference in ability to discard information or clothing objects.  
 
Hypothesis 3 
To test the third hypothesis, a binary logistic regression was used to predict 
incidence of discard (patient did vs. did not discard items) from stage of 
treatment. Logistic regression analysis follows the same principles as linear 
regression, however the underlying assumption is that the dependent variable is 
dichotomous (Hosmer & Lemeshow, 2000), as in the current case. Incidence of 
discard was entered as the dependent variable and stage of treatment entered 
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as the predictor. The lag of incidence of discard was entered as the covariate. 
Simple contrasts with baseline as the reference category were conducted. The 
regression model as a whole was significant, X2 (3) = 108.21, p < .01. Overall, 
the model classifies 69.7% of incidence of discard correctly (75% patient did 
discard, 62% patient did not discard). The Nagelkerke pseudo R2 measure was 
.211. Stage of treatment was significant at all stages: for OPT W2 = 11.6 (3) p < 
.01; OPT+DV W2 = 12.4 (3), p < .01 and follow-up W2 = 5.4, (3), p < .05. The 
odds in favour of the patient discarding were more than seven times higher 
during both OPT (7.13) and OPT+DV (7.72), with a reduction in likelihood 
during the follow-up stage (3.88).  The results support the third hypothesis; 
incidence of discard increased during treatment and follow-up compared to 
baseline.  
 
In order to examine whether the stage of treatment effects could be accounted 
for by the diary variables, the logistic regression analysis was re-run with all 
daily diary variables (living in the past, sentimentality, avoidance, anxiety, 
depression and shame) entered as additional covariates. Stage of treatment 
remained significant for OPT (W2 = 12.05 (3), p < .01), OPT+DV (W2 = 8.81 (3), 
p < .05), but not for follow-up (W2 = 1.66 (3), p > .05). Of the daily diary 
variables, only living in the past (W2 = 5.90 (3), p < .01) sentimentality (W2 = 
12.50 (3), p < .01) and avoidance (W2 = 9.17 (3), p < .01) remained significant 
when entered into the model. This suggests that living in the past, sentimentality 
(i.e. sentimental attachment to objects) and avoidance (i.e. avoidance of 
discard) are partial mediators of incidence of discard (i.e. whether the patient 
does or does not discard). Results support the third hypothesis. 
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Hypothesis 4 
To test the fourth hypothesis, that there would be a significant increase in 
incidence of discard during OPT+DV over and above OPT, due to the addition 
of domiciliary visits, a binary logistic regression was computed, with incidence of 
discard (patient did vs. did not discard) entered as the dependent variable, 
stage of treatment entered as the predictor and the lag of the dependent 
variable entered as a covariate. Repeated contrasts comparing OPT and 
OPT+DV were computed. Results show that there was no significant difference 
in the incidence of discard between OPT and OPT+DV (W2 = .14 (1), p > .05). A 
further ANCOVA was conducted to examine whether there were any significant 
differences in the total volume of objects discarded between OPT and OPT+DV. 
Volume was entered as the dependent variable, stage as the predictor and lag 
of volume entered as the covariates. Repeated contrasts indicated that there 
was no significant difference in the total volume of objects discarded between 
outpatient therapy and therapy augmented by domiciliary visits (t (1) = -.0.61, p 
> .05). Therefore the fourth hypothesis could not be supported; the addition of 
domiciliary visits did not have a significant impact on the patient‟s ability to 
discard, nor the total volume of items discarded.   
 
Hypothesis 5 
To test the hypothesis that there would be reductions in hoarding related 
cognitions, behaviour and affect during OPT, OPT+DV and follow-up compared 
to baseline, ANCOVA was computed. All diary measures (past, sentimentality, 
anxiety, depression, shame, and avoidance) were entered as dependent 
variables, stage of treatment entered as the fixed factor and the lag of each 
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dependent variable entered as covariates. Simple contrasts with baseline used 
as the reference category were conducted.  
 
Figure 3 illustrates mean ratings of each diary measure during each stage. The 
graph indicates all diary measures have a downward trend, with the exception 
of shame which shows a downward trend between baseline and OPT and 
remains stable during OPT+DV. Shame then increases when therapy is ended 
during the follow-up period. All patient daily diary variables showed stability 
during the baseline stage (see Figure 4) indicating that factors were not 
responding solely to therapist contact.  
 
Fig 3. Mean ratings of daily diary variables across study phases 
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Simple contrasts indicated that during the OPT stage compared to baseline, 
there was a statistically significant reduction in sentimentality towards 
possessions (M = 6.93; t(1) = -3.32, p < .01), shame (M = 6.82; t(1) = -2.49 p < 
.01), and avoidance of discard (M = 6.57; t(1) = -3.42, p < .01), but not for 
ratings of living in the past (M = 7.57, t(1) = -0.91, p >.05), anxiety (M = 7.48; 
t(1) = -1.14, p >.05) or depression (M = 7.40; t(1) = -0.44, p >.05). During the 
OPT+DV stage, there was a statistically significant reduction in ratings of living 
in the past (M = 7.08; t(1) = -0.91, p < .05) sentimental towards possessions (M 
= 5.89; t(1) = -6.58 p <.01), less avoidant of discard (M = 5.68, t(1) = -5.98, p 
<.01) less shameful (M = 6.91, t(1) = 2.27, p <.05), but not less anxious (M = 
7.32; t(1) = -1.08, p >.05) or depressed (M = 7.29; t(1) = -0.31, p > .05), 
compared to baseline. During the follow-up stage, mean diary ratings showed 
decreased living in the past (M = 5.85; t(1) = -2.96, p <.01), decreased 
sentimentality towards possessions (M = 5.40; t(1) = -1.39, p <.01) and 
avoidance of discard (M= 5.37; t(1) = -6.09, p <.01), in addition to decreased 
levels of anxiety (M = 6.68; t(1) = -2.60, p <.01), compared to baseline. 
However there was no statistically significant difference in ratings of depression 
(M = 6.75; t(1) = -1.43, p > .05) or shame (M = 7.08; t(1) = -0.71, p > .05). The 
results of the fifth hypothesis can only be partially supported; whilst the 
therapeutic intervention appears to have resulted in statistically significant 
changes in patient ratings of living in the past, sentimentality towards 
possessions, avoidance of discard and anxiety in the follow-up period compared 
to baseline, it does not appear to have impacted on patient self-report of 
feelings of depression or shame.  
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Fig 4. Stability of patient ratings of daily diary variables during baseline 
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DISCUSSION 
Main findings  
The Object-Affect Fusion (OAF) informed CBT treatment protocol employed in 
the current study is an extension to existing recommended CBT treatments for 
compulsive hoarding (e.g. Steketee & Frost, 2007). The OAF component of 
treatment appears to have assisted the patient in separating from and 
discarding previously sentimental and emotional fused items and objects.  
 
The intervention produced reliable improvements in measures of depression, 
general mental health, compulsive acquisition and saving. Clutter in the home 
however only showed reliable change in the upstairs area of the home. It is of 
note that clutter ratings were not collected during the follow-up stage, and as 
such the long-term impact of the intervention upon clutter could not be 
assessed, which is a study flaw.  
 
Total volume of discarded items increased as a result of therapy. Results 
indicated that volume of discard was likely to be partially influenced by 
cognitive, behavioural and emotional factors, namely; rumination around past 
events, sentimental attachment to objects, avoidance behaviour and shame. 
Similarly, initiation of discard was also found to be influenced by rumination 
around the past, sentimentality and avoidance behaviour. Shame did not seem 
to impact upon whether or not the patient initiated discard overall.  
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The overall frequency of the patient‟s discard increased as a result of the 
intervention. A downward trend in frequency of discard during the follow-up 
phase suggests ability to discard may be difficult to maintain without on-going 
therapist support. A longer-term follow-up period would have helped to further 
clarify this finding. 
 
Household waste objects were discarded more frequently than information 
based objects and clothing as a result of treatment. In this preliminary 
investigation, it could be speculated that household waste objects were 
perceived as less intrinsically valuable (e.g. Furby, 1978), less sentimental (e.g. 
Kellett & Knight, 2003; Kellett, 2006) and had less emotional attachment (e.g. 
Frost, Hartl, Frost & Williams, 1995) at the point of discard, than did the 
information objects or clothing. With no measure of intrinsic value, 
sentimentality or emotional attachment for each object discarded, it is not 
possible to confirm this. Further research examining „in-vivo‟ observations of 
hoarding behaviour is thus warranted (e.g. see Smyth & Stone, 2003). This 
would help elucidate the cognitive and emotional components influencing 
decision making at the point of discard, in addition to capturing self-reported 
levels of emotional distress associated with particular objects or possessions.  
 
Although domiciliary visits are hypothesised to enhance both treatment 
adherence and ability to discard in individuals who hoard (e.g. Nesiroglu, et al., 
2004; Steketee & Frost, 2007; Tolin et al., 2007), this is the first study to 
examine the impact of additional domiciliary visits on hoarding outcomes. The 
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current study found no evidence to support the hypothesis that home visits 
would result in increased discard. Rates of discard did not differ significantly 
between the two phases of treatment, suggesting this may not be an essential 
component of hoarding treatment success.   
 
The role of cognitions, behaviour and affect in compulsive hoarding 
The OAF informed CBT intervention resulted in decreased cognitive rumination, 
sentimental attachment to possessions, anxiety and avoidance behaviour, but 
did not result in a decrease in depression or shame. Outcomes of depression 
did decrease however, on the formal BDI-II measure (Beck et al., 1995).  It may 
be the case that the conceptualisation of „depression‟ on the patient self-report 
versus the standardised outcome measure differed in meaning for the patient, 
leading to variability in how this was rated. Furthermore, a global retrospective 
measure of depression may be more susceptible to memory bias towards 
positive emotional states than a daily self-report measure where mood is 
recorded „in the moment‟.  
 
The current study adds to existing research relating to sentimental hoarding 
(e.g. Furby, 1978; Kellett & Knight, 2003; Kellett, 2006). Sentimentality was 
found to be associated with cognitive rumination around past events, anxiety, 
depression and feelings of shame during both treatment stages. During the 
outpatient augmented by domiciliary visits stage, sentimental attachment to 
objects became highly correlated with avoidance behaviour; an association 
which remained during the follow-up period.  In the current case, it is possible 
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that rumination about the past was related to an increased sentimental 
attachment towards possessions (e.g. Frost, Hartl, Christian & Williams, 1995) 
creating difficulties at the point of discard. Objects appear to become „fused‟ 
with emotional meaning and memories in compulsive hoarders (Kellett & Knight, 
2003; Kellett 2006), with the discard of possessions likened to a grief response 
(e.g. Hartl & Frost, 1999; Warren & Ostrom, 1988). Possessions operate as 
safety signals during times of increased stress (Frost, 1995; Hartl & Frost, 
1999), and when the home is threatened or violated (Kellett, 2007).  
    
In line with previous research (Grisham, Steketee & Frost, 2007; Kellett et al., 
2010) high levels of depression and shame were reported in the current study 
during all stages, including follow-up. A highly significant correlation between 
shame, depression and anxiety as the treatment stage commenced, was 
particularly evident. Hoarders often attempt to conceal their difficulties, and 
report that allowing others into their home is experienced as shameful and 
embarrassing (Kellett, 2007; Kellett et al. 2010). In the present study, the 
increased focus on and confrontation of hoarding difficulties during treatment 
and the exposure to the therapist to during the domiciliary visits may have been 
accompanied by shame, anxiety and depression. Frost et al., (1999) noted that 
anticipation of home visits and treatment appeared to trigger a hoarding „state of 
mind‟, characterised by feelings of anxiety at the prospect of having to discard 
possessions (Hartl & Frost, 1999 p.460). 
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Diary ratings of shame remained high across study phases, despite discard 
rates with a further increase during the follow-up period. Achieving a significant 
decrease in shame therefore, whilst desirable may not be necessary for 
hoarding interventions to be effective.   
 
Methodological considerations 
The single patient sample represents the main methodological weakness in the 
current study; results may not generalize to other individuals with compulsive 
hoarding. The results should therefore be considered as exploratory, and need 
to be replicated in much larger samples.  
One particular methodological limitation is the treatment design. The OAF 
component ran across both the outpatient therapy (OPT) and outpatient 
augmented by domiciliary visits (OPT+DV) stages. It is not possible, therefore to 
specify whether OAF treatment (either over and above or in conjunction with 
CBT) was the primary mechanism for change. A different SCED design; 
A/B/C/D whereby B is CBT only; C is OAF only and D is CBT+OAF would have 
clarified whether OAF alone or as an adjunct to CBT is most effective in 
facilitating reduced hoarding.  
 
The patient presented with co-morbid obsessive compulsive disorder (OCD), in 
addition to compulsive hoarding symptoms. The nature of the relationship 
between OCD and compulsive hoarding is still contested (e.g. Pertusa et al., 
2010). Differentiating between hoarders with and without co-morbid OCD in 
research samples is vital (Pertusa et al., 2010) as this may necessitate and 
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dictate different treatment protocols. Whilst no attempts were made to treat the 
OCD in the current patient, the inclusion of an OCD measure (e.g. the Yale-
Brown Obsessive Compulsive Scale (YBOCS; Goodman, Price, Rasmussen, et 
al., 1989) to evidence stability or not of OCD symptoms would have been 
useful. As the patient was receiving pharmacological treatment for OCD 
symptoms via Citalopram, it is possible that this may have had some impact 
upon hoarding symptoms. Citalopram has found to be a useful treatment option 
for compulsive buying (Koran, Choung, Bullock & Smith, 2003); a condition 
thought to share significant association with compulsive hoarding (e.g. Frost & 
Gross, 1993; Frost & Hartl, 1998; Frost, Kim, Morris, Bloss, Murray-Close & 
Skeketee, 1998; Frost, Steketee & Williams, 2002; Mueller, Mueller, Albert, 
Mertens, Silbermann, Mitchell, & de Zwann, 2007). In the current case however, 
the baselines for discard variables were found to be stable, suggesting that 
changes observed were due to the psychological intervention, rather than 
ongoing pharmacotherapy.  
 
The current study utilised a single-case experimental design (SCED) in the 
treatment of an individual compulsive hoarder within clinical practice. As 
previously highlighted, single-case methodologies are a useful and practical 
way of measuring change within conditions that are rare, or which have a 
limited evidence base (Bower & Gilbody, 2010; Turpin, 2001). Evidence derived 
from randomised controlled trials (RCT‟s) is often viewed as the „gold standard‟ 
(Barkham, Stiles, Lambert & Mellor-Clark, 2010); considered by some to be 
more scientifically rigorous and robust than evidence derived from „real-world‟ 
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settings (Wampold, 2009). Real-world research is seen as riddled with 
confounding variables than cannot be easily controlled or manipulated, and for 
this reason RCT‟s often adopt strict participant inclusion/exclusion criteria within 
their studies to reduce threats to internal validity (Bower & Gilbody, 2010). 
However, what RCT‟s may gain in internal validity, they may lose in external 
validity – that is the extent to which findings are generalisable to other 
individuals with similar difficulties seen within everyday clinical contexts (Bower 
& Gilbody, 2010). Whilst RCT research clearly has its benefits as an objective 
scientific methodology, the focus on this approach to the exclusion of other 
forms of evidence (e.g. case studies, SCEDs, behavioural observation) 
disregards the significant impact that real-world research can have in furthering 
the evidence base for an array of psychological difficulties (Barkham et al., 
2010). To some extent, it could be argued that SCED methodologies bridge the 
gap between RCT‟s and evidence derived from real-world research. Indeed, 
evidence from SCED methodology has been seen to be equivalent to that of 
RCT‟s (Chambless & Hollon, 1998).  RCT‟s are resource and time intensive, 
and impractical to conduct in circumstances where clinical conditions or 
populations are rarely encountered (Bower & Gilbody, 2010), such as 
compulsive hoarding.  SCED studies, on the other hand are inexpensive to 
implement and have the added benefit that they address the idiosyncratic needs 
of the particular patient being treated within clinical practice (Newall & Burnard, 
2006).  For future research to progress, the synthesis of research evidence 
gained via both evidence-based practice and practice-based evidence is now 
needed (Barkham et al., 2010). This is likely to have a greater impact on the 
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knowledge base of efficacious treatments, not only for compulsive hoarding; but 
mental health and psychological difficulties more generally (Barkham et al., 
2010).    
 
Conclusions 
The current study presented a 2-year insight into the on-going life of a 
compulsive hoarder, unique within extant empirical research. Compulsive 
hoarding is generally viewed as treatment resistant (Frost & Gross, 1993), with 
knowledge regarding the efficacy and effectiveness of treatment being limited 
(Steketee & Frost, 2003; Tolin, Frost & Steketee, 2007). The OAF informed 
CBT treatment employed was successful in increasing frequency, volume, and 
overall incidence of discard. Additional therapist home visits as a component of 
treatment did not appear to produce a significant difference in discard behaviour 
in this case. The patient demonstrated improvements in ratings of depression, 
general mental health, compulsive acquisition and saving. The present study 
both supports and adds to existing research regarding cognitive and 
behavioural factors implicated in hoarding (e.g. Frost & Hartl, 1996). 
Rumination, sentimentality, anxiety, avoidance and shame all appeared to be 
important factors in compulsive hoarding. The integration of both evidence-
based and practice-based approaches in future studies of compulsive hoarding 
is now warranted, for our clinical understanding of this hard to treat disorder to 
progress.   
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APPENDIX F: PSYCHOMETRIC MEASURES 
 
Brief Symptom Inventory (BSI; Derogatis,1987)  
[REMOVED] 
Beck Depression Inventory (BDI-II; Beck, Steer & Brown, 1995) 
[REMOVED] 
 
Inventory of Interpersonal Problems-32 (IIP-32; Barkham, Hardy & Startup, 
1996)  
[REMOVED] 
 
Compulsive Acquisition Scale (CAS; Frost, Kim, Morris, Bloss, Murray, Close 
& Steketee, 1998) 
[REMOVED] 
 
Saving Inventory – Revised (SI-R; Frost, Steketee & Grisham, 2004) 
 
[REMOVED] 
 
 
Clutter Image Rating (CI-R; Frost, Steketee, Tolin & Renaud, 2008) 
 
[REMOVED] 
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APPENDIX G: RATER INSTRUCTIONS FOR CATEGORISATION AND 
DISCARD OF OBJECTS 
 
Rating task: Categorisation and volume of discarded objects 
 
 
Introduction: 
 
 The purpose of this rating task is to „test‟ two systems for recording: 
 
(a) The types of objects that the hoarder said they threw away each day 
(b) The total „volume‟ i.e. bulk or mass of all of the objects that the hoarder said they 
threw away each day 
 
 You are being asked to try out these systems by rating some example lists of 
objects and   feeding back your experiences 
 
 There are no right or wrong answers! The researcher is simply looking to find 
out whether  
      the categorisation system is good enough to use, or if there are any problems with 
it so   
      it can be changed if necessary 
 
 You will shortly be shown 10 lists of objects thrown away over 10 separate days 
that the hoarder was asked to record in a daily diary   
 
 You will be asked to record: 
 
1.  The category of individual objects thrown away each day 
2.  The total „volume‟ of all objects thrown away each day 
 
 The three main categories for the objects are: (full list overleaf) 
- information based objects 
- household waste objects 
- clothing footwear and linen objects   
 
 However there may be items which fall into none of the three main categories. 
The researcher is interested in finding out which objects are difficult to categorise or 
which do not seem to fit into the three main categories. These should be listed in the 
„other‟ category. There will also be a space for you list those items. 
 
 You will then be asked to use the visual rating scale (overleaf) to estimate how 
much of a typically sized bin bag you think the total items listed would fill. This is on a 
scale from 1-4.  The maximum rating is 4.  
 
 We will rate the lists separately first and then come back as a group and 
discuss our findings. 
 
 Thank you again for taking part in this study. 
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Rating Tools 
 
Object Categories: 
 
 
1. Information 
based objects 
2. Household waste 
objects 
3. Clothing, 
footwear and 
linen objects 
4. Other 
E.g. 
Newspapers   
Magazines     
Leaflets 
Books 
Utility bills 
Photographs 
Computers 
Junk mail 
Cards 
Electronics 
Mobile phones 
CD‟s 
TV 
VCR‟s   
E.g.  
Food  
Carpets 
Packaging 
Curtains 
Cartons 
Rugs 
Cleaning products 
Ornaments 
Cloths  
Crockery 
Bottles 
Toys and games 
Tins 
Furniture (small or 
bulky) 
E.g.  
Shirts 
Pillowcases 
Jumpers 
Quilts  
Coats   
Quilt covers  
Jackets 
Bags 
Shoes/boots  
Trousers 
Bedsheets 
Skirts  
Towels 
Pillows 
E.g. 
Any items that do 
not fit into 
categories 1, 2 or 
3 
 
 
Total ‘volume’ of all objects thrown away: 
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Rating instructions: 
 
1. First look at all the individual items listed 
 
2. Then decide upon a category for each item (e.g. Information, Household, Clothing) 
 
3. If you do not feel the item fits into either of the three main categories, put it in ‘Other’ 
 
3. Make a decision about how many item(s) it represents  
 If it is a single item e.g. ‘magazine’ = 1 item 
 If it is multiple copies of the same item e.g.  ‘5 magazines’ = 5 
items 
 If it is a „pair‟ and item is inseparable, e.g. ‘sunglasses’, 
‘trousers’ = 1 item 
 If it is a „pair‟ and item is separable, e.g. ‘curtains’, ‘shoes’ = 2 
items  
 
4. If it is unclear how many items it represents (e.g. ‘books’) but it is clearly more than 
one item, you should give that item = ‘2’ items 
 
5. Write down your number in the ‘total number in list’ box next to the category you 
have chosen for that item. You may find it easier to keep a running tally. 
 
6. Finally, make a decision around how much volume the TOTAL number of items in 
the list      represents using the bin bag rating scale. How much of a typical sized bin 
bag do you think the items would fill? 
This is up to a maximum rating of 4.   
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Rating example: 
 
 
List: 
 
2 pairs of shoes 3 bottles 
5 magazines              1 Belt  
Paint tins              2 Trousers 
Vase 
Containers 
 
 
Objects listed Total number in list 
Information based objects IIIII (5) 
Household waste objects IIIII  III (8) 
Clothing, footwear and linen objects IIIII II (7) 
Other 0 
 
 
Information based objects:      
5 magazines (5) 
Total = 5 
 
Clothing, footwear and linen objects: 
2 pairs of shoes (4) 
1 belt (1) 
2 trousers (2) 
Total = 7 
 
Household waste objects:      
Paint tins (2)        
Vase (1) 
Containers (2) 
3 bottles (3) 
Total = 8 
  
Other:  
Total = 0 
 
Total ‘volume’ of all objects thrown away: 
 
                                                         
 
   
         1                                  2                                   3                                            4  
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Rating Task 
 
List 1: 
 
 
Cups 
Plates 
Sieve 
6 books 
 
 
Objects listed Total number in list 
Information based objects  
Household waste objects  
Clothing, footwear and linen objects  
Other  
 
Items listed in „other‟ category: 
 
 
 
 
 
 
 
 
 
 
Total ‘volume’ of all objects thrown away: 
 
 
                                                        
 
   
       1                                   2                                   3                                           4 
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List 2: 
 
Candle holder 
2 jumpers 
1 dress 
2 jumpers 
8 braziers 
3 underskirts 
1 belt 
Small table 
 
 
Objects listed Total number in list 
Information based objects  
Household waste objects  
Clothing, footwear and linen objects  
Other  
 
Items listed in „other‟ category: 
 
 
 
 
 
 
 
 
 
Total ‘volume’ of all objects thrown away: 
 
 
                                                         
 
   
         1                                   2                                  3                                            4 
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APPENDIX H: VIDEO RATING TASK INSTRUCTIONS  
 
Video rating task 
 
 You will shortly be shown 4 short videos. Your task is to watch the videos 
as they are presented to you by the researcher and make a judgement 
about the overall level of „clutter‟ shown in that video from „1‟ (not at all 
cluttered) up to a maximum of „9‟ (extremely cluttered).  
 
 You will be given a rating scale with colour photos to help you with your 
decision making before watching the videos.  
 
 Each of the photos in the rating scale has a number (i.e. from 1-9). You 
should choose the photo number that you think best represents the 
level of clutter shown in the video.   
 
 There are no right or wrong answers and this is not a test. Please do not 
discuss your responses with other raters.  
 
 Thank you again for taking part in this study. 
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Video 1: 
Please tick your rating 
 
1 2 3 4 5 6 7 8 9 
         
 
 
Video 2: 
 
Please tick your rating 
 
1 2 3 4 5 6 7 8 9 
         
 
 
Video 3: 
 
Please tick your rating 
 
1 2 3 4 5 6 7 8 9 
         
 
Video 4: 
 
Please tick your rating 
 
1 2 3 4 5 6 7 8 9 
         
 
 
Video 5: 
 
Please tick your rating 
 
1 2 3 4 5 6 7 8 9 
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Video 6: 
 
Please tick your rating 
 
1 2 3 4 5 6 7 8 9 
         
 
 
 
 
 
 
